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LIST OF ABBREVIATIONS 
 
ADIPOQ   adiponectin gene 
ADIPOQ   protein coded by adiponectin gene 
AR1    adiponectin receptor 1 gene 
AR1    protein coded by adiponectin receptor 1 gene 
AR2    adiponectin receptor 2 gene 
AR2    protein coded by adiponectin receptor 2 gene 
HSL    hormone-sensitive lipase gene 
HSL    protein coded by hormone-sensitive lipase 
LEP     leptin gene 
LEP     protein coded by leptin gene 
LPL    lipoprotein lipase 
LPL    protein coded by lipoprotein lipase 
NEFA     non-esterified fatty acids 
PPAR    peroksisome proliferator activated receptor gamma gene 
PPAR    protein coded by peroksisome proliferator activated  
    receptor gamma gene 
SNEB    severe negative energy balance 
SCD    stearoyl-CoA desaturase gene 
SCD    protein coded by stearoyl-CoA desaturase 
TAG    triacylglycerol 
-12    12 days before calving 
+1    1 day after calving 
+7    a week after calving 
g    g-force, relative centrifugal force 
rpm    revolutions per minute 
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1 INTRODUCTION 
 
The selection of high yielding dairy cows is based on their predicted genetic merit. In 
most dairy cow populations the genetic merit is estimated for milk production traits 
(Snijders et al. 2001).  The capability to produce large quantities of milk is partially 
dependent on capability to mobilize fat during early lactation. Milk production and 
development of foetus increase nutrient requirements during the periparturient period. 
Especially during early lactation period the cow fails to meet the energy demand of high 
milk production. Therefore, cows enter a state of negative energy balance. The period of 
SNEB can vary depending on the body condition, feed and the yield of milk (Beever et 
al. 2006). This period also accompanies an increase in the incidence of health problems, 
e.g. resulting in diseases like fatty liver and ketosis (Morris et al. 2009). The increased 
need for nutrients during the postpartum period is partially met by the increase in 
insulin resistance (Butler et al. 2003).  
Adipose tissue has been considered a fat depot but recent studies have shown that it has 
important roles in various autocrine, paracrine and endocrine functions (Pittas et al. 
2004). A decrease in the lipogenesis in dairy cows during the postpartum stage is 
associated with the negative energy balance (Chilliard et al. 2000). The insulin secretion 
affects the regulation of lipogenic enzymes (Sumner et al. 2011). Lipogenesis is linked 
with changes in the plasma concentration of insulin and substrates inducing formation 
of fatty acids (Pittas et al. 2004). The increase in the non-esterified fatty acids (NEFA) 
in the plasma might alter the expression of genes or activity of enzymes involved in 
lipogenesis.  
The lipolysis in the adipose tissue results in the release of NEFA in to the plasma. The 
increase in the fat mobilization due to re-esterification and lipolysis in the early 
lactation counts for the negative energy balance (Sadri et al. 2010). The progress of the 
lactation period is marked by an increase in the esterification of fatty acids and a steady 
rate of lipolysis (Sumner & McNamara 2007).  
Various studies of adipose tissue of periparturient dairy cows have led to the deeper 
understanding about metabolic adaptations to lactation (Namara et al. 1986, Sumner & 
McNamara 2007, Sadri et al. 2010, Sadri et al. 2011). The main objective of this study 
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was to analyze how feed energy and fibre contents affect the expression of lipogenic 
and lipolytic genes in high yielding cows. 
 
2 LITERATURE REVIEW 
2.1 Effects of SNEB on dairy cows 
Severe negative energy balance (SNEB) is affecting high yielding dairy cows after 
parturition. It is known to predispose cows to periparturient diseases (Lemor et al. 
2009). The high yielding cows encounter SNEB during the postpartum period, when the 
energy needed for maintenance and lactogenesis is more than the energy intake through 
diet (Carthy et al. 2010). The SNEB can last for few weeks and during that period, fatty 
acid catabolism can lead to accumulation of triglycerides in liver and affect its function. 
This can augment the concentration of lipid metabolites in blood to cause oxidative 
stress (Morris et al. 2009).  
The increase in the rate of metabolism and weight results in changes in liver during the 
early postpartum period.  In extreme cases it can lead to hepatic lipidosis and ketosis 
(Kokkonen et al. 2004). The dry period corresponds to the growth of the foetus where 
the requirement for the nutrients is at its peak. The demand for glucose, fatty acids and 
proteins further increase after calving for the production of milk for lactation. NEFA 
from the breakdown of lipids are used by the liver where they are oxidized to produce 
energy (Wathes et al. 2007). The increasing metabolic process can in turn use body 
reserves such as fat and protein. This might cause mitochondrial fatty acid oxidation in 
tissues like liver. This may be linked to weak immune system and make the animal 
more susceptible to infections (Morris et al. 2009).  
The metabolic changes in the body can affect the mechanism of uterine repair, resulting 
in the reduced fertility (Wathes et al. 2009). The activity of ovary regains its form 
during the SNEB but it has severe effects on the conception rates (Fenwick et al. 2008). 
The changes in the negative energy balance can alter the expression of genes and cause 
inhibitory impact on the cell growth and repair. They decrease the DNA replication and 
also abnormally affect the cell cycle (McCarthy et al. 2010).  
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2.2 Feed intake and SNEB 
The improvement in genetic selection, nutrition and management has increased the 
production of milk yield of dairy cows. One important factor here is the feed intake 
especially during the early lactation when the cows suffer from severe negative energy 
balance (Veerkamp et al. 2000). Inadequate feed intake has caused numerous problems 
in the postpartum cow. It has led to metabolic disorders, reduced fertility and adverse 
effects on the production of milk (Holtenius et al. 2003). Hence, nutritional strategies 
should be developed that increase the feed intake which will enhance BCS, the 
mobilization of lipid and reduce its storage in liver (Douglas et al. 2006).  
An easy method to increase the feed intake is to increase the energy density of feed 
either by fat and carbohydrates or decreasing the forage (Andersen et al. 2002). It has 
been noticed that overfeeding during the postpartum period has led to high risks such as 
appetite depression and reduced milk synthesis. As mentioned above SNEB is 
responsible for various metabolic disorders like, ketosis, lipidosis, ruminal acidosis and 
decrease in the reproduction rate, hence, various studies have been done in order to cope 
up with this metabolic disorder by increasing intake of feed in the postpartum period 
(Reist et al. 2003). The ability of liver to oxidize long chain fatty acids can be helpful in 
reducing hepatic lipidosis. A study shows that fatty acid metabolism is related to feed 
and hormones (Andersen et al. 2002). 
One strategy is a protein supplement in feed which can increase the milk production. 
This includes grass silage, a crude protein content which can affect on the performance 
of animal but still produces good quality milk (Beever et al. 2006). Another method to 
enhance BCS is to increase the energy density by adding concentrates out of cereal and 
low calorie supplements to a high forage meal. This will reduce the accumulation of TG 
in liver as compared to cows fed with lower or higher energy diets (Douglas et al. 
2006). In line to this strategy to improve SNEB is to reduce the calorie needed for milk 
production in dairy cows. Intake of milk-fat depressing diets can prevent the 
accumulation of fat in the body. Addition of glucose rich feed, lower milk fat yield, 
reducing the energy needed to produce milk would enhance the energy partitioning to 
other tissues. Therefore, the SNEB will be improved with lower rates of fat mobilization 
(Knegsel et al. 2005). Thus high energy diet can yield positive results during SNEB and 
will have reduced risk of fatty acid infilteration in liver (Andersen et al. 2002). 
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2.3 SNEB and insulin resistance 
A number of changes take place in the dairy cows around parturition. One component of 
SNEB is insulin resistance which means a failure of target organs to respond normally 
to the action of insulin (Pittas et al. 2004). The reduced fertility of dairy cows has been 
related to negative energy balance and insulin resistance (Wathes et al. 2009). The 
increase in need for glucose, fatty acids and amino acids is required for the production 
of milk during the period of lactation. The liver takes up the fatty acids and oxidizes 
them either to carbon dioxide for energy demand or to ketones for use by the body. 
Most of the cows undergo the stage of ketosis during the initial months of lactation. 
This is important in balancing the blood glucose level (Wathes et al. 2007).  
During calving the amount of urea in the blood is not stable. It is marked by the increase 
in amino acid catabolism in muscles and various tissue proteins which also meets the 
demand for glucose (Wathes et al. 2007). Thus parturition and lactation initiates 
adaptations to increase the energy by decreasing lipogenesis, increasing lipolysis and 
the levels of insulin in serum (McNamara et al. 1986). Insulin regulates the function of 
adipose tissues such as TG synthesis, glucose metabolism and inhibiting lipolysis. 
These actions are triggered when the receptor binds to insulin and produces signaling 
pathway (Arner 2003). 
The major adaptations of the ruminants during early lactations accounts for the 
increased reduced responsiveness of the adipose tissues towards insulin (Block et al. 
2001). The demand for energy is fulfilled by insulin resistance in adipose tissues which 
decreases the uptake of peripheral glucose and increases the continuous flow of 
nutrients from mother to the placenta (Chagas et al. 2009). The further increase in 
demand for energy after calving decreases the amount of insulin during early lactation 
(Ingvartsen et al. 2006). Insulin resistance impairs the functioning of adipocyte which is 
mediated by the increase in the fatty acids in adipose tissues (Arner  2003).  
The amount of fat and the adipose tissue distribution affects the insulin resistance. 
Adipose tissue, the fat depot of the body produces proteins called as adipocytokines that 
might alter insulin metabolism through autonomic pathways. The differences in the 
breeds to produce milk are partially dependent on the response of tissues to insulin and 
also on the feed intake rich in glucose and fatty acids by the mammary tissues during 
the lactation (Chagas et al. 2009).  
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2.4 Role of adipose tissues in lipolysis and lipogenesis 
Adipose tissue regulates energy metabolism, insulin sensitivity, endocrine, reproductive 
functions, inflammation and immunity (Ahima & Flirt 2000). It helps in overcoming the 
energy deficiency in tissues during the early lactation. Negative energy balance 
increases the amount of non- esterified fatty acid concentration in plasma by breaking 
down fat molecules in adipose tissues (Wathes et al. 2007). The mobilization of adipose 
tissue in response to energy deficient conditions is associated with metabolic and 
endocrine changes in dairy cows during early lactation (Sadri et al. 2010). It is involved 
in a variety of functions such as, glucose homeostasis, energy balance and metabolism 
of lipid mostly regulated by insulin (Arner  2003).  
Adipose tissue metabolizes energy in two ways by first storing it during pregnancy and 
then releasing it for development and maintenance of the body. The hormonal changes 
increase the energy need in the animal and hence, the lipid synthesis (lipogenesis) 
decreases and the breaking down of fat molecules (lipolysis) increases (Namara et al. 
1986). This metabolic regulation support a process called as homeorhesis common 
amongst ruminants. This adaptation in dairy cows shows the basic principle of energy 
metabolism and its regulation (Chilliard et al. 2000). In adipose tissues during early 
lactation NEFA are released in response to synthesis of milk and energy metabolism. 
This process leads to the storage of glucose and amino acids to be used by the 
mammary gland (Chilliard et al. 2000).  
The increase in NEFA in adipose tissue due to SNEB orients the tissue towards 
catabolism and reduces the insulin sensitivity (Sadri et al. 2010). During late gestation 
and early lactation, dairy cows undergo a moderate degree of peripheral tissue insulin 
resistance to support the uptake of glucose by mammary tissues (Lemor et al. 2009). 
Adipose tissue can be classified into 2 types- subcutaneous and visceral. The lipolysis is 
more in visceral as compared to subcutaneous as insulin plays an important role as anti 
lipolytic agent (Arner  2003). The cow copes up with the SNEB with decreased adipose 
tissue lipogenesis and increased lipolysis. The response varies in the animal from excess 
needed for the maintenance of body and milk production to increase in feed intake with 
less fat in the body (Sumner & McNamara 2007).  
Reduced insulin sensitivity in peripheral tissue could change the relative rates of 
lipolysis and lipogenesis. However, little is known about the changes in mRNA 
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expression of key lipogenic and lipolytic enzymes in adipose tissue around parturition 
(Sadri et al. 2010). 
 
2.5 Quantitative PCR in gene expression studies 
Quantitative Polymerase Chain Reaction (qPCR) has been a popular method to quantify 
gene expression (Peirson et al. 2003).  The quantification produced can either be exact 
number of copies (absolute) or relative amount (relative) in reference to the DNA input. 
The presence of one or more specific sequences in the sample can lead to detection as 
well as quantification of DNA. The absolute quantification relies on copy number of the 
transcript by forming standard curve in respect to PCR signal. The relative 
quantification explains the change in gene expression by taking a reference group under 
consideration (Peirson et al. 2003).  
The quantification of gene expression relatively requires the use of equations, 
assumptions and testing to completely understand the data. One of the methods includes 
the delta CT method which is used to calculate gene expression from qPCR experiments 
(Livak et al. 2001). The use of this application is to determine the effect of treatment on 
the expression of internal control gene. The main steps to this approach include the 
selection of an internal control gene. The PCR should be performed by using cDNA 
including the experimental gene and control gene with same efficiency. The final data 
should be converted in to delta CT by using raw CT values statistically (Livak et al. 
2001).  
During the last few years, the gene expression analysis has been used to characterize the 
physiological processes in farm animals. It also provided a deeper insight into the 
metabolic process and functional states of the organism. Several studies were conducted 
in order to know the alterations in gene expression by negative energy balance 
(McCarthy et al. 2010, Wathes et al. 2009 & Morris et al. 2009). The data obtained from 
the gene expression data can give us an idea about the ways to reduce the risk of 
metabolic disorders in dairy cows and improve their reproductive performance. 
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2.6 Genes in this study 
Genes in this study include adiponectin (ADIPOQ), secreted from adipose tissue. It is 
important for lipid metabolism, maintaining blood glucose level and insulin sensitivity 
(Lemor et al. 2009). Leptin (LEP) is a hormone secreted by adipose tissue and plays an 
important role in increasing lipolysis and decreasing liver lipogenesis (Sadri et al. 
2010). The peroksisome proliferator activated receptor gamma (PPAR-γ) acts as a 
transcriptional regulator for fat specific genes (Rosen et al. 1999). Adiponectin receptor-
1 (AR1) and receptor-2 (AR2) are liver specific hormones that are involved in fatty acid 
oxidation (Loor et al. 2010). Lipoprotein lipase (LPL) is expressed in large amounts by 
adipose tissue to facilitate the uptake of NEFA in peripheral tissues by hydrolyzing 
triglyceride rich lipoproteins (Ranganathan et al. 2006). Stearoyl-CoA desaturase (SCD) 
is a regulatory enzyme which helps in the synthesis of unsaturated fatty acids in liver 
(Ntambi et al. 1995).  Hormone-sensitive lipase (HSL) is a major enzyme contributing 
to the breakdown of triacylglycerol in adipose tissue (Schweiger et al. 2006).  
 
3 OBJECTIVES 
The objectives of this master’s thesis study: 
1) To quantitate the expression of lipolysis and lipogenesis associated genes during 
late pregnancy and early lactation. 
2) To analyse if feed energy and fibre contents have effect to the expression of 
lipolysis and lipogenesis associated genes in dairy cows. 
Understanding the changes in expression levels of genes before and after calving 
based on feed intake and energy would increase our understanding of the regulation 
of metabolic pathways and help to improve the health and reproductive performance 
of the dairy cows. 
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4 MATERIALS AND METHODS 
4.1 Animals and feeding experiment 
Samples and data sets for this study were obtained from the feeding experiment 
conducted from September 2010 to April 2011 in Viikki Experimental Farm at the 
University of Helsinki. Sixteen multiparous Ayrshire cows were divided into two 
groups: (1) grass silage fed group (control) and (2) silage-roughage mixture fed group 
(experiment). Feeding experiment started 8 weeks before expected parturition. In the 
experiment, the treatments included feeding of grass silage (1) and a mixture of grass 
silage, wheat straw and rapeseed meal (55%: 40%: 5%) (2). During the dry period, the 
metabolizable energy was 35% higher in the group 1 than in the group 2. 
These two groups control and experiment were formed based on the pairs of animals. 
Prior to the treatments, cows were divided into pairs according their expected calving 
date, parity and body condition score (BCS). After calving, all cows were offered wilted 
grass silage with high amounts of commercial concentrate. Subcutaneous adipose tissue 
samples were collected 12 days before, one day and 7 days after parturition from cows 
under local anesthesia at 1600-1700. Tissue samples were snap frozen using liquid 
nitrogen and then stored at -80 C. The final number of analysed animals was 14 because 
two animals were excluded from the experiment during experimental period (Table 1). 
Table 1.  List of animals and the schedule for collection of tissue samples. 
 
Animal Id 
 
Name of sample 
 
-12 
 
 
+1 
 
+7 
 
440 TUC 18-10-2010 11-11-2010 18-11-2010 
449 Tenkapoo 01-11-2010 18-11-2010 24-11-2010 
560 Assamix 8-12-2010 26-12-2010 2-1-2011 
544 Yncell 11-11-2010 30-11-2010 7-12-2010 
510 Virkatati 12-12-2010 21-12-2010 27-12-2010 
403 Sibylla 1-2-2011 20-2-2011 27-2-2011 
459 Utopia 27-12-2010 3-1-2011 10-1-2011 
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447 Ticoria 2-3-2011 23-3-2011 30-3-2011 
455 Unetta 25-10-2011 8-11-2010 15-11-2010 
460 Ukulele 7-2-2011 20-2-2011 27-2-2011 
436 Tox tox 26-1-2011 7-2-2011 15-2-2011 
525 Fantastico 15-2-2011 14-3-2011 9-3-2011 
540 Yam yam 10-1-2011 25-1-2011 1-2-2011 
439 Tavernassa 21-12-2010 31-12-2010 7-1-2011 
 
 
4.2 Extraction of total RNA 
 
Total RNA was extracted using RNeasy Lipid Tissue Kit (Qiagen GmbH, Hilden, 
Germany).  A slice of adipose tissue (< 100 mg) was disrupted and homogenised in 1 ml 
of QIAZOL lysis reagent using the homogenizator (TissueRuptor, Qiagen GmbH, 
Hilden, Germany) and incubated at room temperature for 5 min. Then 200 µl of 
chloroform was added, followed by vigorous shaking for 15 sec and incubation at room 
temperature for 2-3 min.  
A centrifuge was set to 4°C and the sample was centrifuged at 12,000g for 15 min. The 
upper aqueous phase was transferred to a new tube and mixed with equal amount of 
70% ethanol and vortexed. The sample was transferred to a column placed in a 2 ml 
tube and centrifuged at 10,000 rpm for 15 sec. After this, 700µl of RW1 buffer was 
added to the column and centrifuged at 10,000 rpm for 15 sec. The same step was 
followed by addition of 500µl of RPE buffer to the column and it was centrifuged at 
10,000 rpm for 15 sec. This step was repeated at the same rpm for 2 min.  
The column was placed in a new tube and centrifuged at full speed for 1 min. The 
column was again placed in 1.5ml tube and total RNA was eluted adding 50 µl of 
RNase free water to the column and then it was centrifuged at 10,000 rpm for 1 min. 
The extracted sample was divided into two parts (1.5µl for RNA quality check and 48.5 
µl for further analyses) and stored at - 80°C. 
 
4.3 RNA quality analyses 
 
The quality of total RNA was analyzed using Agilent Bioanalyzer 2100 chip 
electrophoresis system (Agilent Technologies, Santa Clara, CA, USA).The RNA 6000 
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Nano dye concentrate was allowed to equilibrate to room temperature for 30 min, 
followed by a vortex of 10 min and then 1 µl of dye concentrate was added to 65 µl of 
filtered gel. The solution was vortexed well and then centrifuged at 13,000g at room 
temperature for 10 min.  
A new RNA 6000 chip was placed into the priming station and 9µl of the gel-dye mix 
was pipetted out into the well marked G. The plunger was positioned at 1 ml and the 
priming station was closed. The plunger was pressed until it was held by the chip. After 
30 sec the tip was released. The plunger was pulled back after 5 sec to its previous 
position. The priming station was opened and 9 µl of gel-dye mix was pipetted out in 
the remaining wells. 2.5µl of the RNA 6000 Nano marker was added to all of the 12 
wells including the well for the ladder. 1µl of prepared ladder was also added to the 
well. In all the 12 sample wells, 1 µl of samples were added and in the unused wells the 
marker was added.  
The chip was vortexed for 1 min at 2400 rpm and placed in the bioanalyzer within 5 
min. The quality and concentration of total RNA were also measured by the 
spectrophotometer by placing 1µl of the sample on the NanoDrop 1000 (Thermo 
Fischer Scientific, Wilmington, USA) and measuring the absorbance at wavelengths 
260 nm and 280 nm. 
 
4.4 cDNA preparation 
 
cDNA was prepared by using Transcriptor First Strand cDNA Synthesis Kit (Roche 
Diagnostics GmbH, Mannheim, Germany). ). All the reagents were thawed and 
centrifuged before starting the procedure. In a sterile, thin walled PCR tube, the primer 
template mixture was prepared for 20 µl reaction. The reaction components, their 
volumes and concentrations are shown in Table 2.  
 
Table 2.  Reaction components for the first phase. 
Component Volume  (µl) 
 
Final concentration 
Total RNA 12 1µg total RNA 
Anchored oligo (dT)18 
primer, 50pmol/µl 
 
1 
 
2.5µM 
Total volume 13  
 
15 
 
 
The template mixture was denatured by heating the tube at 65°C for 10 min in a thermal 
block cycler with a heated lid. This step ensured the denaturation of secondary 
structures of RNA. This step was followed by immediate cooling on ice. The remaining 
components of cDNA mixture were added to the tube in the order shown in Table 3. 
 
Table 3.  Reaction components for the second phase. 
Component Volume (µl) Final concentration 
Transcriptor Reverse 
transcriptase reaction 
buffer, 5×conc. 
4 1×( 8mM Mgcl2) 
Protector RNase Inhibitor, 
40 U/µl 
0.5 20U 
Deoxynucleotide Mix, 
10mM each 
2 1mM each 
Transcriptor Reverse 
Transcriptase, 20 U/µl 
0.5 10U 
Final volume 20  
 
The reagents were centrifuged and the tubes were placed on the thermal block cycler at 
temperature of 25°C for 10 min followed by 55°C for 30 min. The cDNA preparation 
was based on the primer used and the length of the target mRNA. The Transcriptor 
reverse transcriptase was inactivated by heating at 85°C for 5 min. The reaction was 
stopped by keeping it on ice and later stored at -25°C for longer durations. 
 
4.5 Quantitative PCR 
 
Quantitative PCR (qPCR) was done by using Light Cycler 480 SYBR Green I Master 
kit (Roche Diagnostics GmbH, Mannheim, Germany). The first three plates were made 
for genes adiponectin (ADIPOQ), adiponectin receptor-2 (AR2), leptin (LEP), 
lipoprotein lipase (LPL), stearoyl-CoA desaturase (SCD) and the last three plates for the 
remaining genes tumor necrosis factor alfa (TNF-α), carnitine palmitoyltransferase 1 
(CPT-1), peroksisome proliferator activated receptor gamma (PPAR-γ), adiponectin 
receptor-1 (AR1), hormone-sensitive lipase (HSL). The internal control was eukaryotic 
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translation initiation factor 3 subunit K (EIF3K).  Primer sequences and lengths for PCR 
products are given in Table 4. 
Table 4. List of the studied genes, lengths of PCR products and primer sequences of 
genes. 
Gene 
 
PCR 
product 
(bp) 
Forward primer 
 
Reverse primer 
 
Source 
ADIPOQ 
70 
GATGGCACCCCTGGTGAGAA CACCAGTGTCACCCTTAGGACCA 
Kari Elo, 
unpublished 
AR1 
118 
GGCTCTACTACTCCTTCTAC ACACCCCTGCTCTTGTCTG 
Lemor et al. 
2009 
AR2 
200 
GGCAACATCTGGACACATC CTGGAGACCCCTTCTGAG 
Lemor et al. 
2009 
EIF3K 
125 
CCAGGCCCACCAAGAAGAA 
TTATACCTTCCAGGAGGTCCATG
T 
Kadegowda et 
al. 2009 
HSL 
102 
GAGTTTGAGCGGATCATTCA TGAGGCCATGTTTGCTAGAG 
Sumner & 
McNamara 
2007 
LEP 
55 
CTGTGCCCATCCGCAAGGT CCAGTGACCCTCTGTTTGGAGGA 
Kari Elo, 
unpublished 
LPL 
101 ACACAGCTGAGGACACTTGC
C GCCATGGATCACCACAAAGG 
Bionaz & 
Loor 2008 
PPARγ 
171 CTTGTGAAGGATGCAAGGGT
TTCTT 
CCAAACCTGATGGCATTATGAG
ACA 
Kari Elo, 
unpublished 
SCD 
101 
TCCTGTTGTTGTGCTTCATCC GGCATAACGGAATAAGGTGGC 
Bionaz & 
Loor 2008 
 
The reaction volume in PCR was 10µl (7.5µl Master Mix and 2.5µl of cDNA) and 
PCRs were pipette on the 384-well plates using epMotion 5075 pipetting robot 
(Eppendorf AG, Hamburg, Germany). The total volume of cDNA solution was 80µl 
(diluted 1:8, 10µl of cDNA and 70µl ddH2O ). The cDNA was manually pipetted into 
96-well plate in the following order, A1, A2, B1, B2 and so on. The primer solution was 
prepared by diluting 6µl of forward and reverse primer with 108µl of ddH2O to get a 
concentration of 5pmol/µl. The master mix was prepared for six genes by adding 128µl 
ddH2O, 85µl of primer solution and 425µl of Roche’s 2X master mix. Following the 
previous step, 79µl of the master mix was manually pipetted into the 96-well plate and 
correctly positioned on the epMotion 5075 worktable.  
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All the pipette racks were placed on B2 and B3 positions, 96-well cDNA plate to 
position C1, optical 384-well plate to C2 and 96-well master mix plate to C3 positions 
on the epMotion 5075 worktable. Reactions were performed in a  Light Cycler 480 Real 
Time PCR instrument (Roche Diagnostics GmbH, Mannheim, Germany ). 
 
4.6 Statistical analyses 
The threshold cycle value (Ct) is the starting point for exponential amplification in the 
PCR reaction. Typical amplification curves with different starting points for exponential 
amplification are shown in Figures 1-3.  
 
Figure 1. Amplification curve with Ct=27 for EIF3K (internal control gene). 
 
 
Figure 2. Amplification curve with Ct=31 for  AR2 gene. 
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Figure 3. Amplification curve with Ct=29 for  HSL gene. 
 
The concentration of the target cDNA influences the value of threshold cycle. Using 
qPCR the differences in expression levels of control and the experimental genes were 
evaluated (EIF3K, ADIPOQ, AR1, LEP, LPL, SCD, PPAR, AR2 and HSL) using 4 
replicates. Transcriptional levels of these genes were compared using the method of 
Livak & Schmittgen (2001). ΔCt values were calculated as follows: 
  
ΔCt = (average Ct of replicates) studied gene - (average Ct of replicates) internal control gene 
 
The ΔCt values were subtracted from 10 (10-ΔCt) to get positive values before 
analyses. Most of the statistical analyses were performed using 10-ΔCt as variable. 
All data analyses were conducted using R statistical software package (http://www.r-
project.org/).  Distributions of the data sets were analysed using the Shapiro Wilk 
normality test. The gene expression differences between groups (control and 
experiment) and among time points (-12, +1 and +7) were studied using non-parametric 
methods (Kruskal Wallis Rank Sum test and Wilcoxon Rank Sum test). Differences 
among time points include repeated measurements from same animals, and thus data 
consists of dependent measurements. Differences between two time points were 
analysed using Wilcoxon Rank Sum test for dependent measurements. All differences 
were considered statistically significant at risk levels P≤ 0.05.  
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5 RESULTS 
 5.1 Quality and quantity of RNA  
The quality and quantity of RNA were measured by automated capillary gel 
electrophoresis on a Agilent Bioanalyzer 2100. The samples had 28S/18S ratios (rRNA 
ratio) ranging from 0.5 to 1.5 and RNA Integrity Number (RIN) between 3.0 to 8.0 
which indicated the acceptable quality of RNA (Table 5). Another method to detect the 
purity and quantity of the RNA was spectrophotometrical. Total RNA samples were 
measured by Nanodrop spectrophotometer giving for most samples absorption values 
close to 2.0 implying the acceptable quality of samples (Table 5).  
 
Table 5.  RIN values, rRNA ratio and spectrophotometer absorption at 260/280. 
 
 
Agilent Bioanalyzer 2100 NanoDrop 
Animal Id 
 
Time period rRNA ratio RIN 260/280 ng/µl 
440 -12 1.1 7.6 3.87 0.7 
440 +1 0.9 7.2 1.98 21.2 
440 +7 1.1 7.6 1.96 85.2 
449 +1 1 7.5 1.97 27 
449 +7 0 N/A 1.4 5.3 
560 -12 0 4.3 1.43 4.7 
560 +1 1.2 6.1 2.17 23.2 
560 +7 0 N/A -1.24 -0.9 
544 -12 0.9 5.4 1.72 7.5 
544 +7 0.9 5.9 1.62 44.2 
510 -12 0 N/A 3.27 -4.1 
510 +1 0 3.8 1.97 28.3 
510 +7 1 6.3 1.82 6.1 
403 -12 1 N/A 2.32 22.9 
403 +1 1 7.7 1.94 18.7 
403 +7 1 7.1 1.91 14.5 
459 -12 1 7 1.92 6.2 
459 +1 0.8 6.7 1.98 23.9 
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447 -12 1.1 7.6 2.01 23.5 
447 +1 0 5.1 1.96 30.5 
447 +7 1 7.1 1.84 16.4 
455 -12 2 N/A 2.02 11.6 
455 +1 0.6 6.2 1.7 19.9 
455 +7 0 1.8 1.63 14.7 
460 -12 0 1.7 1.93 19.9 
460 +1 0.6 6.4 1.87 10.8 
460 +7 1.2 7.1 1.93 35.1 
436 +1 1 7.4 1.68 6.6 
436 +7 1.3 6.9 2.06 43.6 
525 -12 0 3.3 2.42 -1.9 
525 +1 0 3.7 2.01 14.6 
525 +7 0 N/A 1.99 8.2 
540 -12 0.7 5.9 1.99 41.6 
540 +1 0.5 5.5 1.5 3.7 
540 +7 0.6 6 2.02 25 
439 -12 0 N/A 2 38.2 
439 +7 0 N/A 1.85 22 
 
 
5.2 Statistical analyses 
The null hypothesis for the Shapiro Wilk normality test is that the data is normally 
distributed. If the P value listed in the output is less than 0.05 then the data is not 
normally distributed. If the value of P is greater than 0.05 then the null hypothesis is not 
rejected and the data is normally distributed. Our data set is not completely normally 
distributed (Table 5). Based on this observation nonparametric tests were used in further 
analyses. 
   
Table 5.  Results of Shapiro Wilk normality test. 
Values ADIPOQ AR2 LEP LPL SCD PPAR AR1 HSL 
W 0.8971 0.9469 0.979 0.9779 0.9223 0.8421 0.8607 0.9892 
p 0.001366* 0.07689 0.6966 0.5979 0.00807* 0.000* 0.0001* 0.9597 
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*P< 0.05 = no normal distribution of data 
 
The null hypothesis states that the there is no difference between control and treatment. 
When gene expressions levels were compared between grass silage fed group (control) 
and silage-roughage mixture fed group (experiment) using 10-ΔCt as a variable, the 
expression of AR2 (P=0.036) did not follow the null hypothesis (Table 6).  There is 
potential difference (P=0.064) in gene expression between groups in LEP gene as well 
(Table 6). 
 
Table 6. Statistical analyses by Kruskal Wallis Rank Sum test (degree of freedom=1) 
Values ADIPOQ AR2 LEP LPL SCD PPAR AR1 HSL 
Chi-squared 0.6751 4.3961 3.4358 1.4395 0 0.7409 0.1992 0.7864 
P 0.4113 0.0360* 0.0638 0.2302 0.9792 0.3894 0.6553 0.3752 
*Treatment was significantly different (P<0.05) from control. 
Differences between time points in the mRNA expression levels of all genes were 
analysed using Wilcoxon Rank Sum test. Statistically significant differences were 
observed in LEP (+1 vs +7 days, P=0.055) and in SCD (-12 vs. +1 days, P=0.017 and -
12 vs. +7 days, P=0.017) (Table 7).  
 
Table 7.  Statistical analyses by Wilcoxon Rank Sum test 
LOG 
VALUE 
 
ADIPOQ AR2 LEP LPL SCD 
 
PPAR 
 
AR1 
 
HSL 
dCt12&d
ct7 
V 57 65 59 41 15 56 48 41 
P 0.8077 0.4631 0.7148 0.5016 0.0166* 0.8552 0.8077 0.5016 
dCt7&dC
t1 
V 48 21 14 62 55 64 60 59 
P 0.8077 0.1698 0.05461* 0.583 0.9032 0.5016 0.6698 0.7148 
dCt12&d
Ct1 
V 56 54 38 44 15 73 65 61 
P 0.8552 0.9515 0.391 0.6257 0.0166* 0.2166 0.4631 0.6257 
*mRNA expression of genes are significantly different at different time points (P<0.05) 
Whether genes were down- or upregulated in different groups of animals can be 
concluded from averages of 10-ΔCt (Tables 8-10). The gene expression of AR2 and 
LEP was smaller in the control group than in the experiment group (Tables 8-10). 
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It is evident that LEP is downregulated in the control group from -12 to +7 days from 
calving because 10-ΔCt values are decreasing from 9.819 to 7.803 (AVG1 in Tables 8-
10). In the experiment group, there is both down- (-12 vs. +1) and upregulation (+1 vs. 
+7) (Fig. 4). Similar pattern was seen in the expression of SCD. The gene is 
downregulated from -12 to +7 in the control group but both down- (-12 vs. +1) and 
upregulated (+1 vs. +7) in the experiment group (Tables 8-10).  
 
Table 8. Mean of mRNA expression on lipogenic and lipolysis related genes in adipose 
tissue 12 days before calving. 
Gene Name AVG1 AVG2 SD1 SD2 
ADIPOQ 13.13893 11.31542 1.862484 1.978331 
AR2 9.763571 10.01202 1.610167 0.813276 
LEP 9.819405 10.42655 1.856294 1.626801 
LPL 11.24786 11.23702 1.512752 1.086468 
SCD 13.61143 12.67333 2.577535 2.411493 
PPAR 11.00964 11.60321 2.016041 1.023636 
AR1 5.171667 5.516786 1.317601 1.077812 
HSL 7.669643 8.503333 2.632312 1.725175 
AVG1&2 = average of control and experiment groups, SD1&2= Standard deviation of 
control and experiment groups. 
 
Table 9. Mean of mRNA expression on lipogenic and lipolysis related genes in adipose 
tissue one day after calving. 
Gene Name AVG1 AVG2 SD1 SD2 
ADIPOQ 12.32571 13.61 2.772565 1.008344 
AR2 9.112083 10.06042 1.657691 1.748904 
LEP 8.0125 8.7525 0.994279 1.699306 
LPL 10.68393 10.80042 1.902427 1.572661 
SCD 10.69429 9.5675 2.974829 2.032585 
PPAR 11.54905 11.64958 1.238916 0.86585 
AR1 5.515357 5.57625 1.758742 0.987131 
HSL 8.731429 7.5475 2.829273 2.407774 
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Table 10. Mean of mRNA expression on lipogenic and lipolysis related genes in 
adipose tissue one week after calving. 
Gene Name AVG1 AVG2 SD1 SD2 
ADIPOQ 11.55012 13.91298 2.647986 2.634173 
AR2 8.735167 11.08722 1.128083 1.83393 
LEP 7.8025 10.46708 1.589297 1.679485 
LPL 9.719524 11.80798 2.767039 1.882248 
SCD 9.614762 11.32869 2.438923 2.216924 
PPAR 11.18964 11.82393 1.309604 0.936286 
AR1 5.673571 6.24 0.473068 2.907868 
HSL 7.089286 8.391071 1.454178 1.826168 
There were no significant differences in the gene expression of ADIPOQ, LPL, PPAR, 
AR1 and HSL either between control and experiment or among time points (Tables 6-
10).  
 
Figure 4.  Pattern of LEP gene expression during weeks relative to parturition. 
 
6 DISCUSSIONS 
6.1 Background to gene expression analyses 
Adipose tissue is marked by lipolysis and reduced fatty acid synthesis during the early 
lactation (Vernon et al. 2005). Insulin, responsible for glucose metabolism acts against 
lipolysis (Sadri et al. 2010). During the late pregnancy and early lactation the insulin 
resistance increases in adipose tissues of dairy cows so that the need for nutrients during 
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the postpartum period is met (Butler et al. 2003). This can interfere with the increasing 
amount of NEFA. High levels of plasma NEFA can reduce insulin sensitivity and 
further lead to diseases like ketosis and fatty acid accumulation (Vernon et al. 2005). In 
contrast to the current study, the increased intake of feed during the prepartum period 
increased the plasma insulin concentration (Holtenius et al. 2003). However, the energy 
intake did not show any changes in the level of NEFA before and after calving 
(Kokkonen et al., unpublished). This difference in the lipid mobilization could be a 
result of the minute difference in the weight gains between the treatment groups of 
animal. 
 In previous studies, it has been observed that large differences in the weight gains 
during the dry period increase the plasma NEFA concentration after calving (Holtenius 
et al. 2003 and Douglas et al. 2006). Adipose tissue controls the mobility of fatty acids 
according to the requirement of the body. High energy intake by group1 in this study 
affected the plasma NEFA levels during the experiment but the differences were not 
statistically significant (Kokkonen et al., unpublished). The cows in this group needed 
more insulin to lower down the rate of lipolysis. A decrease in the lipolysis of fatty 
acids shows an improvement in the glucose metabolism and insulin sensitivity 
(Schweiger et al. 2006).  
 
6.2 mRNA abundance level of lipogenesis and lipolysis related genes 
ADIPOQ is a cytokine produced in the adipose tissue which plays an important role in 
lipid metabolism and maintaining energy levels in the body (Sadri et al. 2010). Hepatic 
expression of AR2 in this study was down regulated in control (P<0.05 and P<0.10) as 
compared to experiment group. Three biopsy time points were used in this study with 
48 animals in total. In concordance with the study by (Lemor et al. 2009) significant 
time effect was reported in AR1 and AR2 expression in subcutaneous adipose tissue 
postpartum compared with prepartum cows. This might lead to reduced insulin 
sensitivity in the adipose tissue further leading to a decrease in the glucose metabolism 
and increased rate of lipolysis. The study involved 2 biopsy time points with a varied 
time interval. This was in contrast to the study by (Sadri et al. 2011) which observed no 
significant time effect in the expression of adiponectin or its receptors. The study had 
three biopsy time points from 27 animals which varied in time difference as compared 
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to our samples. The body adaptations to the metabolic changes during the transition 
period allows for these changes in the expression of genes. However no significant 
differences were found in the expression of ADIPOQ and AR1 in the current study in 
subcutaneous fat. 
LEP is another regulatory cytokine produced by adipose tissues. It has multifunctional 
roles in decreasing the lipogenesis in adipose tissues or liver and increasing the lipolysis 
in adipose tissues (Havel et al. 2004). The LEP gene expression was found to be more 
in experiment group during the relative days of calving (-12, +1, +7) as compared to 
control group (Figure 4). The decrease in the expression of LEP was due to the negative 
energy balance produced by the reduced levels in plasma insulin. In accordance to the 
study by (Sadri et al. 2010) insulin controls the secretion of LEP in lactating cows. This 
state of the dairy cow may be related to the conservation of energy for development of 
body and foetus growth (Chilliard et al. 2005). This was found to be in contrast to the 
studies by (Chilliard et al. 2001) where the LEP plasma concentration was lower in 
moderately fed group as compared to high energy fed group. The decrease in expression 
can be correlated to the fatness in dairy cows which in turn correlated with loss of 
appetite and reduction in energy efficiency (Chilliard et al. 2000). Similar studies by 
(Block et al. 2001) showed that LEP mRNA levels were high at 1 and 4 weeks after 
calving as compared to first weeks of lactation. 
SCD is an enzyme involved in the synthesis of fatty acids. The mRNA abundance of 
gene in the current study was upregulated in group 1 before calving and one day after 
calving. However, one week after calving, the mRNA abundance of SCD in the 
subcutaneous fat was more in group2 as compared to group1. This is in contrast to the 
studies by (Kinsella et al. 1972) where the regulation of SCD increased more than 40% 
after calving. The studies by (Bionaz et al. 2008) accounted for 23% of the relative 
mRNA abundance of SCD after calving. Thus the fatty acid determination in milk by 
SCD depends on selective uptake of TAG by mammary tissues and its utilization during 
lactation. Another similar study by (Loor et al. 2007) was contrasting to the current 
study where feed restriction and ketosis are associated with down regulation of 
desaturation of fatty acid. Ruminants with hepatic lipidosis have reduced amount of 
circulating lipoproteins as a result of down regulation of SCD. 
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The lipolysis of TAG by HSL is the rate limiting step in the process of lipolysis (Sadri 
et al. 2010). In relation to studies made by (Sumner & McNamara 2007) the expression 
of HSL increased in the prepartum cows as compared to postpartum. The rate of 
lipolysis was more on the day of after parturition. This proposed that the current study 
had lower rate of lipolysis as the recent study shows no significant changes in the 
mRNA abundance of HSL in the plasma which is in accordance with the studies made 
by (Sadri et al. 2010). The fatty acids are accumulated in the adipose tissue by de novo 
synthesis and uptake from the circulation.  
LPL plays a major role in the uptake of fatty acids from the circulation. Its regulation is 
dependent on the nutrition and metabolic function of the body (Vernon et al. 2005). 
There were no significant differences in the expression of LPL in the recent study which 
shows that cows are still affected by the negative energy balance to incorporate 
lipogenesis (Sadri et al. 2010). Recent studies (Harvatine et al. 2009) showed an 
upregulation in the SCD and LPL genes related to fatty acid synthesis in adipose tissues. 
The experimental setup for this study included biopsy samples on 14 day after calving 
as compared to our biopsy time points for the study. The nuclear hormone PPAR is 
responsible for lipid metabolism, energy homeostasis and differentiation of adipose 
tissues (Lemberger et al. 1996). 
 In our study no specific significance was found in the expression of PPAR. In a recent 
study by (Bionaz et al. 2008) showed that the changes in the adipocytes might be related 
to stages of lactation and this could report for a down regulation of the expression of the 
gene. Here, the mRNA abundance was found to be less than 1% which was similar to 
our observation indicated that the mammary tissue of the lactating cow has low amounts 
of subcutaneous fat. 
 
7 CONCLUSIONS 
The feed had an effect on the expression of adipose related genes in this experiment. 
The regulation of lipolysis and lipogenic genes showed variations ranging from the 
period of prepartum to postpartum in dairy cows. The genes involved in the synthesis of 
fatty acids were down regulated only after 7 days of calving in control group with an 
increase in the expression in the experiment group.  
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The rate of lipolysis was also low due to the difference in the level NEFA in the plasma 
as well as the restricted feeding strategy during the prepartum period. This proves that 
the adipose tissue was unable to cover the energy needed for maintenance and lactation. 
Understanding the role of adipose tissue in lipid metabolism, feed intake and lactation 
would help reducing the metabolic disorders and its consequences in ruminants. 
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10 APPENDICES 
Appendix 2. The Ct values of EIF3K, ADIPOQ, AR2, LEP, LPL and SCD 
 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
440 12 ADIPOQ 20.74 20.95 21.45 20.6 0.372245 20.935 17.63 16.93 16.86 17.44 0.3786379 17.215 0.530973948 -3.72 0 
440 1 ADIPOQ 20.38 19.59 20.41 20.44 0.410731 20.205 18.51 17.8 17.93 18.48 0.3677862 18.18 0.551331721 -2.025 1.695 
440 7 ADIPOQ 20.48 20.37 20.37 20.8 0.203388 20.505 20.86 20.39 20.31 19.91 0.3897328 20.3675 0.439611571 -0.1375 3.5825 
440 12 AR2 20.74 20.95 21.45 20.6 0.372245 20.935 21.46 21.66 21.73 21.92 0.1899781 21.6925 0.417921444 0.7575 0 
440 1 AR2 20.38 19.59 20.41 20.44 0.410731 20.205 22.4 21.94 22.51 22.71 0.3262923 22.39 0.52456331 2.185 1.4275 
440 7 AR2 20.48 20.37 20.37 20.8 0.203388 20.505 22.66 23.48 23.72 23.54 0.4711688 23.35 0.513192621 2.845 2.0875 
440 12 LEP 20.74 20.95 21.45 20.6 0.372245 20.935 23.71 23.42 24.21 24.33 0.426722 23.9175 0.566267016 2.9825 0 
440 1 LEP 20.38 19.59 20.41 20.44 0.410731 20.205 23.43 24.37 24.28 24.64 0.5228767 24.18 0.664906008 3.975 0.9925 
440 7 LEP 20.48 20.37 20.37 20.8 0.203388 20.505 25.6 24.86 24.62 24.5 0.4932545 24.895 0.533541626 4.39 1.4075 
440 12 LPL 20.74 20.95 21.45 20.6 0.372245 20.935 20.38 20.41 20.34 19.77 0.3046856 20.225 0.481040539 -0.71 0 
440 1 LPL 20.38 19.59 20.41 20.44 0.410731 20.205 22.27 20.61 21.63 21.61 0.6856627 21.53 0.799270501 1.325 2.035 
440 7 LPL 20.48 20.37 20.37 20.8 0.203388 20.505 23.73 23.62 24.35 24.47 0.4295249 24.0425 0.475245551 3.5375 4.2475 
440 12 SCD 23.42 23.34 23.34 22.87 0.251181 23.2425 22.43 22.54 22.71 22.52 0.1169045 22.55 0.277052943 -0.6925 0 
440 1 SCD 22.62 22.6 22.6 22.7 0.04761 22.63 26.43 26.31 26.39 25.85 0.2680174 26.245 0.272213152 3.615 4.3075 
34 
 
 
440 7 SCD 30.67 30.45 29.83 30.46 0.362802 30.3525 31.59 30.32 30.82 31.53 0.6074263 31.065 0.707525029 0.7125 1.405 
560 12 ADIPOQ 27.96 28.59 28.82 28.35 0.367423 28.43 29.31 28.76 28.31 27.78 0.6511016 28.54 0.747618441 0.11 0 
560 1 ADIPOQ 23.72 22.38 22.81 23.99 0.756417 23.225 21.81 21.44 21.32 20.82 0.40885 21.3475 0.859840101 -1.8775 -1.9875 
560 7 ADIPOQ 27.81 27.44 27.44 
 
0.21362 27.56333 24.48 24.28 24.4 24.3 0.0929157 24.365 0.232952069 
-
3.19833333 
-
3.308333333 
560 12 AR2 27.96 28.59 28.82 28.35 0.367423 28.43 
 
29.64 27.78 28.58 0.9330238 28.66667 1.00276285 0.23666667 0 
560 1 AR2 23.72 22.38 22.81 23.99 0.756417 23.225 24.66 24.99 25.46 24.71 0.3666515 24.955 0.840595027 1.73 1.493333333 
560 7 AR2 27.81 27.44 27.44 
 
0.21362 27.56333 26.91 27.52 26.61 26.75 0.4008637 26.9475 0.454230118 
-
0.61583333 -0.8525 
560 12 LEP 27.96 28.59 28.82 28.35 0.367423 28.43 
 
27.28 27.47 27.81 0.2685144 27.52 0.45508241 -0.91 0 
560 1 LEP 23.72 22.38 22.81 23.99 0.756417 23.225 25.72 24.55 25.68 25.72 0.5786406 25.4175 0.952361101 2.1925 3.1025 
560 7 LEP 27.81 27.44 27.44 
 
0.21362 27.56333 
 
24.29 26.73 27.37 1.6253 26.13 1.639278296 
-
1.43333333 
-
0.523333333 
 
 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
560 12 LPL 27.96 28.59 28.82 28.35 0.367423 28.43 27.34 27.49 27.53 27.31 0.1087428 27.4175 0.383177505 -1.0125 0 
560 1 LPL 23.72 22.38 22.81 23.99 0.756417 23.225 22.97 23.49 23.53 23.33 0.2550817 23.33 0.798268961 0.105 1.1175 
560 7 LPL 27.81 27.44 27.44 
 
0.21362 27.56333 26.94 27.65 27.58 27.45 0.3208842 27.405 0.385486705 -0.158333 0.854166667 
35 
 
 
560 12 SCD 27.96 28.59 28.82 28.35 0.367423 28.43 23.54 22.98 23.52 22.85 0.3591077 23.2225 0.513768755 -5.2075 0 
560 1 SCD 23.72 22.38 22.81 23.99 0.756417 23.225 23.8 23.67 24.34 23.8 0.2980352 23.9025 0.81301394 0.6775 5.885 
560 7 SCD 27.81 27.44 27.44 
 
0.21362 27.56333 27.46 27.53 27.94 27.78 0.2224672 27.6775 0.30842341 0.11416667 5.321666667 
544 12 ADIPOQ 28.79 28.69 26.84 27.56 0.937337 27.97 24.37 24.49 24.77 24.33 0.1986622 24.49 0.958157955 -3.48 0 
544 1 ADIPOQ 
  
27.83 27.95 0.084853 27.89 23.35 22.85 22.91 22.58 0.3191003 22.9225 0.33018934 -4.9675 -1.4875 
544 7 ADIPOQ 28.43 27.76 25.37 25.45 1.574471 26.7525 19.44 18.86 18.9 18.52 0.3803507 18.93 1.619760785 -7.8225 -4.3425 
544 12 AR2 28.79 28.69 26.84 27.56 0.937337 27.97 26.6 27.55 27.53 27.61 0.4828647 27.3225 1.054399513 -0.6475 0 
544 1 AR2 
  
27.83 27.95 0.084853 27.89 24.58 24.36 24.69 24.72 0.1631717 24.5875 0.183915742 -3.3025 -2.655 
544 7 AR2 28.43 27.76 25.37 25.45 1.574471 26.7525 21.65 21.74 22.38 22.28 0.3707088 22.0125 1.617523828 -4.74 -4.0925 
544 12 LEP 28.79 28.69 26.84 27.56 0.937337 27.97 
 
27.59 28.41 27.72 0.4407191 27.90667 1.035776681 
-
0.06333333 0 
544 1 LEP 
  
27.83 27.95 0.084853 27.89 25.7 26.71 26.6 25.95 0.4920027 26.24 0.499266128 -1.65 
-
1.586666667 
544 7 LEP 28.43 27.76 25.37 25.45 1.574471 26.7525 23.5 23.33 24.88 23.7 0.7014925 23.8525 1.723673403 -2.9 
-
2.836666667 
544 12 LPL 28.79 28.69 26.84 27.56 0.937337 27.97 25.61 25.75 25.78 25.54 0.1140175 25.67 0.944245731 -2.3 0 
544 1 LPL 
  
27.83 27.95 0.084853 27.89 24.45 24.55 24.39 24.49 0.06733 24.47 0.108320512 -3.42 -1.12 
544 7 LPL 28.43 27.76 25.37 25.45 1.574471 26.7525 21.8 21.82 22.36 22.38 0.3235223 22.09 1.607365858 -4.6625 -2.3625 
544 12 SCD 28.79 28.69 26.84 27.56 0.937337 27.97 23.64 23.63 23.98 23.52 0.1992277 23.6925 0.958275361 -4.2775 0 
544 1 SCD 
  
27.83 27.95 0.084853 27.89 24.77 25.96 25.59 25.54 0.4997666 25.465 0.506918797 -2.425 1.8525 
544 7 SCD 28.43 27.76 25.37 25.45 1.574471 26.7525 23.95 24.5 24.38 23.72 0.365 24.1375 1.616225026 -2.615 1.6625 
36 
 
 
449 12 ADIPOQ 28.57 29.52 28.91 
 
0.481352 29 24.52 24.62 24.5 24.66 0.0772442 24.575 0.487510684 -4.425 0 
449 1 ADIPOQ 24.71 24.61 24.9 24.8 0.123962 24.755 21.66 20.77 20.6 20.48 0.5350623 20.8775 0.549234316 -3.8775 0.5475 
449 7 ADIPOQ   23.64 23.33 22.38 0.656531 23.11667 19.68 19.34 18.85 18.8 0.4196328 19.1675 0.779182264 
-
3.94916667 0.475833333 
449 12 AR2 28.57 29.52 28.91 
 
0.481352 29 27.38 26.75 26.8 26.95 0.28624 26.97 0.560029761 -2.03 0 
449 1 AR2 24.71 24.61 24.9 24.8 0.123962 24.755 24.76 24.63 24.86 25.72 0.4940563 24.9925 0.509370527 0.2375 2.2675 
449 7 AR2 
 
23.64 23.33 22.38 0.656531 23.11667 23.66 23.68 24.33 24.5 0.4357656 24.0425 0.787987944 0.92583333 2.955833333 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
449 12 LEP 28.57 29.52 28.91 
 
0.481352 29 26.66 27.49 26.92 26.69 0.384621 26.94 0.616143923 -2.06 0 
449 1 LEP 24.71 24.61 24.9 24.8 0.123962 24.755 26.77 
 
26.51 26.88 0.19 26.72 0.22686266 1.965 4.025 
449 7 LEP 24.66 23.64 23.33 22.38 0.939588 23.5025 24.79 25.67 25.72 26.73 0.793153 25.7275 1.229600206 2.225 4.285 
449 12 LPL 28.57 29.52 28.91 
 
0.481352 29 25.65 25.5 25.98 25.54 0.2177728 25.6675 0.528322818 -3.3325 0 
449 1 LPL 24.71 24.61 24.9 24.8 0.123962 24.755 23.54 22.98 23.39 23.37 0.2390258 23.32 0.26925824 -1.435 1.8975 
449 7 LPL 
 
23.64 23.33 22.38 0.656531 23.11667 23.41 23.38 23.61 23.9 0.2395134 23.575 0.698856208 0.45833333 3.790833333 
449 12 SCD 28.57 29.52 28.91 
 
0.481352 29 24.84 25.52 24.78 25.5 0.4049691 25.16 0.629046898 -3.84 0 
449 1 SCD 24.71 24.61 24.9 24.8 0.123962 24.755 22.75 22.76 23.28 22.77 0.2601282 22.89 0.288155051 -1.865 1.975 
449 7 SCD 
 
23.64 23.33 22.38 0.656531 23.11667 21.4 21.9 21.69 21.65 0.2051016 21.66 0.687822652 
-
1.45666667 2.383333333 
510 12 ADIPOQ 
            
0 0 0 
510 1 ADIPOQ 25.66 25.59 25.51 25.49 0.078049 25.5625 27.49 27.54 27.58 27.63 0.0594418 27.56 0.098107084 1.9975 1.9975 
37 
 
 
510 7 ADIPOQ 23.7 23.61 22.9 21.96 0.805497 23.0425 19.74 19.62 19.71 19.56 0.0826136 19.6575 0.809722175 -3.385 -3.385 
510 12 AR2 
            
0 0 0 
510 1 AR2 25.66 25.59 25.51 25.49 0.078049 25.5625 28.76 29.64 27.66 30.32 1.1502319 29.095 1.152876836 3.5325 3.5325 
510 7 AR2 23.7 23.61 22.9 21.96 0.805497 23.0425 23.99 24.75 25.53 25.5 0.7303595 24.9425 1.087313202 1.9 1.9 
510 12 LEP 
            
0 0 0 
510 1 LEP 25.66 25.59 25.51 25.49 0.078049 25.5625 26.44 27.57 
  
0.7990307 27.005 0.802833524 1.4425 1.4425 
510 7 LEP 23.7 23.61 22.9 21.96 0.805497 23.0425 26.61 24.93 26.64 
 
0.9787237 26.06 1.267566566 3.0175 3.0175 
510 12 LPL 
            
0 0 0 
510 1 LPL 25.66 25.59 25.51 25.49 0.078049 25.5625 27.79 27.61 27.48 27.86 0.1725302 27.685 0.189362967 2.1225 2.1225 
510 7 LPL 23.7 23.61 22.9 21.96 0.805497 23.0425 25.8 25.91 25.93 26.31 0.2224672 25.9875 0.835653437 2.945 2.945 
510 12 SCD 
            
0 0 0 
510 1 SCD 25.66 25.59 25.51 25.49 0.078049 25.5625 30.35 28.98 28.53 28.42 0.8870551 29.07 0.890482079 3.5075 3.5075 
510 7 SCD 23.7 23.61 22.9 21.96 0.805497 23.0425 24.8 25.59 25.93 24.73 0.5916854 25.2625 0.999458187 2.22 2.22 
403 12 ADIPOQ 25.44 25.92 25.84 25.93 0.231858 25.7825 21.7 21.49 21.8 22.22 0.3068523 21.8025 0.384599359 -3.98 0 
403 1 ADIPOQ 24.74 24.3 24.55 24.54 0.180254 24.5325 20.31 20.5 20.43 20.44 0.0795822 20.42 0.197040605 -4.1125 -0.1325 
403 7 ADIPOQ 24.53 24.56 24.64 24.7 0.07719 24.6075 19.84 20.23 19.93 19.95 0.1685972 19.9875 0.185427434 -4.62 -0.64 
403 12 AR2 25.44 25.92 25.84 25.93 0.231858 25.7825 26.4 26.56 26.54 26.22 0.1570563 26.43 0.280044639 0.6475 0 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
403 1 AR2 24.74 24.3 24.55 24.54 0.180254 24.5325 24 24.4 24.76 24.57 0.3236639 24.4325 0.370472671 -0.1 -0.7475 
38 
 
 
403 7 AR2 24.53 24.56 24.64 24.7 0.07719 24.6075 24.54 24.38 24.52 24.71 0.1352467 24.5375 0.155724115 -0.07 -0.7175 
403 12 LEP 25.44 25.92 25.84 25.93 0.231858 25.7825 25.65 25.43 25.69 25.78 0.1486327 25.6375 0.275408787 -0.145 0 
403 1 LEP 24.74 24.3 24.55 24.54 0.180254 24.5325 25.82 26.62 26.26 25.98 0.3508086 26.17 0.39440884 1.6375 1.7825 
403 7 LEP 24.53 24.56 24.64 24.7 0.07719 24.6075 25.62 24.96 25.45 24.97 0.336353 25.25 0.345096605 0.6425 0.7875 
403 12 LPL 25.44 25.92 25.84 25.93 0.231858 25.7825 23.5 23.42 23.51 23.79 0.1617611 23.555 0.282710099 -2.2275 0 
403 1 LPL 24.74 24.3 24.55 24.54 0.180254 24.5325 23.5 23.35 23.38 23.51 0.0818535 23.435 0.197968853 -1.0975 1.13 
403 7 LPL 24.53 24.56 24.64 24.7 0.07719 24.6075 24.52 23.94 24.63 23.96 0.3637192 24.2625 0.371819849 -0.345 1.8825 
403 12 SCD 25.44 25.92 25.84 25.93 0.231858 25.7825 19.89 20.39 20.56 20.48 0.301441 20.33 0.380295937 -5.4525 0 
403 1 SCD 24.74 24.3 24.55 24.54 0.180254 24.5325 20.55 21.75 21.52 21.42 0.5251666 21.31 0.555240188 -3.2225 2.23 
403 7 SCD 24.53 24.56 24.64 24.7 0.07719 24.6075 26.47 26.95 26.49 26.5 0.2320022 26.6025 0.244506305 1.995 7.4475 
459 12 ADIPOQ 26.25 26.53 25.59 26 0.398863 26.0925 21.5 21.67 21.39 21.6 0.1219289 21.54 0.417083125 -4.5525 0 
459 1 ADIPOQ 24.69 24.83 25.53 24.93 0.37 24.995 21.4 21.58 21.37 21.43 0.0932738 21.445 0.381575681 -3.55 1.0025 
459 7 ADIPOQ 27.79 26.85 27.23 26.93 0.425989 27.2 24.93 25.43 24.89 24.9 0.2622181 25.0375 0.500224949 -2.1625 2.39 
459 12 AR2 26.25 26.53 25.59 26 0.398863 26.0925 23.91 24.57 24.63 24.77 0.3826225 24.47 0.552713006 -1.6225 0 
459 1 AR2 24.69 24.83 25.53 24.93 0.37 24.995 24.77 23.57 23.81 23.93 0.5219195 24.02 0.639765582 -0.975 0.6475 
459 7 AR2 27.79 26.85 27.23 26.93 0.425989 27.2 27.53 
 
28.37 27.87 0.4225321 27.92333 0.6 0.72333333 2.345833333 
459 12 LEP 26.25 26.53 25.59 26 0.398863 26.0925 23.87 24.4 23.98 24.59 0.3410767 24.21 0.524809489 -1.8825 0 
459 1 LEP 24.69 24.83 25.53 24.93 0.37 24.995 26.72 26.47 25.98 26.57 0.3202603 26.435 0.489353315 1.44 3.3225 
459 7 LEP 27.79 26.85 27.23 26.93 0.425989 27.2 27.66 28.71 28.47 26.81 0.8614087 27.9125 0.960984738 0.7125 2.595 
459 12 LPL 26.25 26.53 25.59 26 0.398863 26.0925 23.27 22.98 23.55 23.33 0.2348581 23.2825 0.462871472 -2.81 0 
39 
 
 
459 1 LPL 24.69 24.83 25.53 24.93 0.37 24.995 24.83 24.74 24.54 24.66 0.1231192 24.6925 0.389946578 -0.3025 2.5075 
459 7 LPL 27.79 26.85 27.23 26.93 0.425989 27.2 27.49 26.39 26.88 27.32 0.492409 27.02 0.651101631 -0.18 2.63 
459 12 SCD 26.25 26.53 25.59 26 0.398863 26.0925 18.83 18.67 19.44 17.67 0.7342286 18.6525 0.835573655 -7.44 0 
459 1 SCD 24.69 24.83 25.53 24.93 0.37 24.995 23.34 23.63 23.74 23.56 0.1687947 23.5675 0.406683743 -1.4275 6.0125 
459 7 SCD 27.79 26.85 27.23 26.93 0.425989 27.2 29.47 29.58 27.86 28.54 0.8150409 28.8625 0.919651202 1.6625 9.1025 
447 12 ADIPOQ 25.31 25.73 25.93 25.56 0.262853 25.6325 21.4 21.36 21.44 20.89 0.257083 21.2725 0.367672862 -4.36 0 
447 1 ADIPOQ 25.85 25.55 25.31 25.59 0.221133 25.575 21.82 21.65 21.66 21.46 0.1472809 21.6475 0.265690923 -3.9275 0.4325 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
447 7 ADIPOQ 24.84 25.53 25.82 25.47 0.412674 25.415 20.43 19.79 19.87 19.95 0.2875181 20.01 0.502957917 -5.405 -1.045 
447 12 AR2 25.31 25.73 25.93 25.56 0.262853 25.6325 24.96 24.83 24.42 24.58 0.2430878 24.6975 0.358027001 -0.935 0 
447 1 AR2 25.85 25.55 25.31 25.59 0.221133 25.575 25.76 25.39 25.95 26.42 0.4285635 25.88 0.482251663 0.305 1.24 
447 7 AR2 24.84 25.53 25.82 25.47 0.412674 25.415 24.64 23.86 24.42 25.55 0.7030588 24.6175 0.815224918 -0.7975 0.1375 
447 12 LEP 25.31 25.73 25.93 25.56 0.262853 25.6325 24.37 24.65 24.6 24.43 0.1337597 24.5125 0.29492937 -1.12 0 
447 1 LEP 25.85 25.55 25.31 25.59 0.221133 25.575 27.8 27.32 27.48 26.96 0.349285 27.39 0.413400532 1.815 2.935 
447 7 LEP 24.84 25.53 25.82 25.47 0.412674 25.415 25.88 25.47 25.54 24.91 0.4020779 25.45 0.576165485 0.035 1.155 
447 12 LPL 25.31 25.73 25.93 25.56 0.262853 25.6325 23.33 23.39 23.44 22.92 0.2376272 23.27 0.354342113 -2.3625 0 
447 1 LPL 25.85 25.55 25.31 25.59 0.221133 25.575 23.75 23.9 23.96 24.43 0.2935984 24.01 0.367559519 -1.565 0.7975 
447 7 LPL 24.84 25.53 25.82 25.47 0.412674 25.415 23.49 23.36 24.44 22.97 0.6237788 23.565 0.747930478 -1.85 0.5125 
447 12 SCD 25.31 25.73 25.93 25.56 0.262853 25.6325 19.79 20.2 21.3 19.85 0.7004046 20.285 0.748103157 -5.3475 0 
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447 1 SCD 25.85 25.55 25.31 25.59 0.221133 25.575 24.38 24.37 24.61 24.25 0.1504161 24.4025 0.267441582 -1.1725 4.175 
447 7 SCD 24.84 25.53 25.82 25.47 0.412674 25.415 23.91 23.95 24.38 24.53 0.3096638 24.1925 0.515937658 -1.2225 4.125 
455 12 ADIPOQ 25.88 26.31 25.98 26.38 0.244728 26.1375 21.43 21.58 21.48 21.44 0.0684957 21.4825 0.254132511 -4.655 0 
455 1 ADIPOQ 25.34 25.23 25.79 25.51 0.243909 25.4675 21.81 21.73 21.77 21.35 0.2125245 21.665 0.323509402 -3.8025 0.8525 
455 7 ADIPOQ 25.93 25.55 25.77 25.51 0.196638 25.69 21.51 21.66 21.54 21.56 0.065 21.5675 0.207103034 -4.1225 0.5325 
455 12 AR2 25.88 26.31 25.98 26.38 0.244728 26.1375 25.68 25.66 25.93 25.53 0.1671327 25.7 0.29635283 -0.4375 0 
455 1 AR2 25.34 25.23 25.79 25.51 0.243909 25.4675 25.61 24.73 24.88 24.74 0.418967 24.99 0.484793771 -0.4775 -0.04 
455 7 AR2 25.93 25.55 25.77 25.51 0.196638 25.69 25.42 24.82 25.46 25.32 0.2959167 25.255 0.355293306 -0.435 0.0025 
455 12 LEP 25.88 26.31 25.98 26.38 0.244728 26.1375 25.69 26.31 25.84 25.29 0.4213767 25.7825 0.487288416 -0.355 0 
455 1 LEP 25.34 25.23 25.79 25.51 0.243909 25.4675 25.91 25.66 25.78 24.71 0.5462905 25.515 0.598268334 0.0475 0.4025 
455 7 LEP 25.93 25.55 25.77 25.51 0.196638 25.69 26.47 25.78 25.27 25.6 0.506162 25.78 0.543016267 0.09 0.445 
455 12 LPL 25.88 26.31 25.98 26.38 0.244728 26.1375 23.88 23.83 24.44 23.86 0.2923896 24.0025 0.381291664 -2.135 0 
455 1 LPL 25.34 25.23 25.79 25.51 0.243909 25.4675 24.55 24.48 23.97 24.44 0.2639444 24.36 0.359386051 -1.1075 1.0275 
455 7 LPL 25.93 25.55 25.77 25.51 0.196638 25.69 24.71 24.51 24.55 24.62 0.0877021 24.5975 0.215309854 -1.0925 1.0425 
455 12 SCD 25.88 26.31 25.98 26.38 0.244728 26.1375 23.33 23.69 24.44 23.72 0.4650806 23.795 0.525539405 -2.3425 0 
455 1 SCD 25.34 25.23 25.79 25.51 0.243909 25.4675 27.39 27.54 27.5 27.4 0.0741058 27.4575 0.254918288 1.99 4.3325 
455 7 SCD 25.93 25.55 25.77 25.51 0.196638 25.69 26.45 26.57 26.95 26.85 0.2340228 26.705 0.305668666 1.015 3.3575 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
460 12 ADIPOQ 26.36 
 
26.51 26.31 0.104083 26.39333 23.28 23.22 22.87 23.52 0.2683747 23.2225 0.287851235 
-
0 
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3.17083333 
460 1 ADIPOQ 25.51 24.95 24.83 24.94 0.306526 25.0575 21.67 21.87 21.75 21.63 0.1058301 21.73 0.324281257 -3.3275 
-
0.156666667 
460 7 ADIPOQ 25.89 26.77 25.99 26.61 0.439811 26.315 22.32 22.45 22.24 22.33 0.0866025 22.335 0.448255879 -3.98 -0.80916666 
460 12 AR2 26.36 
 
26.51 26.31 0.104083 26.39333 27.81 27.28 27.55 27.69 0.2279437 27.5825 0.250582654 1.18916667 0 
460 1 AR2 25.51 24.95 24.83 24.94 0.306526 25.0575 25.4 25.46 25.62 25.46 0.0943398 25.485 0.320715346 0.4275 
-
0.761666667 
460 7 AR2 25.89 26.77 25.99 26.61 0.439811 26.315 26.78 26.84 26.49 26.65 0.1551344 26.69 0.466368953 0.375 
-
0.814166667 
460 12 LEP 26.36 
 
26.51 26.31 0.104083 26.39333 28.51 27.68 
 
28.48 0.4707795 28.22333 0.482147972 1.83 0 
460 1 LEP 25.51 24.95 24.83 24.94 0.306526 25.0575 27 27.56 27.42 27.8 0.3356089 27.445 0.45452356 2.3875 0.5575 
460 7 LEP 25.89 26.77 25.99 26.61 0.439811 26.315 28.97 
 
28.41 27.89 0.5401234 28.42333 0.696539063 2.10833333 0.278333333 
460 12 LPL 26.36 
 
26.51 26.31 0.104083 26.39333 26.5 
 
25.99 25.83 0.3499047 26.10667 0.365057073 
-
0.28666667 0 
460 1 LPL 25.51 24.95 24.83 24.94 0.306526 25.0575 25.55 25.51 24.84 25.7 0.3821867 25.4 0.489923463 0.3425 0.629166667 
460 7 LPL 25.89 26.77 25.99 26.61 0.439811 26.315 26.83 26.57 25.89 25.88 0.4823812 26.2925 0.652782506 -0.0225 0.264166667 
460 12 SCD 26.36 
 
26.51 26.31 0.104083 26.39333 26.89 26.93 26.54 26.7 0.1804624 26.765 0.208326667 0.37166667 0 
460 1 SCD 25.51 24.95 24.83 24.94 0.306526 25.0575 24.46 25.45 26.43 25.36 0.8054191 25.425 0.861776266 0.3675 
-
0.004166667 
460 7 SCD 25.89 26.77 25.99 26.61 0.439811 26.315 
   
27.33 #DIV/0! 27.33 #DIV/0! 1.015 0.643333333 
436 12 ADIPOQ 29.69 29.73 29.82 29.75 0.054391 29.7475 25.98 25.44 25.21 24.97 0.4316634 25.4 0.435076622 -4.3475 0 
436 1 ADIPOQ 29.96 29.36 29.27 28.58 0.565177 29.2925 23.83 24.28 23.55 23.36 0.3997082 23.755 0.692236713 -5.5375 -1.19 
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436 7 ADIPOQ 30.56 30.72 30.49 30.34 0.157771 30.5275 
 
31.66 32.53 32.66 0.5437217 32.28333 0.566149274 1.75583333 6.103333333 
436 12 AR2 29.69 29.73 29.82 29.75 0.054391 29.7475 31.57 32.95 32.78 31.66 0.7259477 32.24 0.727982372 2.4925 0 
436 1 AR2 29.96 29.36 29.27 28.58 0.565177 29.2925 29.97 29.59 29.84 29.56 0.1981582 29.74 0.59890873 0.4475 -2.045 
436 7 AR2 30.56 30.72 30.49 30.34 0.157771 30.5275 
    
#DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 
436 12 LEP 29.69 29.73 29.82 29.75 0.054391 29.7475 31.83 31.77 31.7 
 
0.0650641 31.76667 0.084803695 2.01916667 0 
436 1 LEP 29.96 29.36 29.27 28.58 0.565177 29.2925 29.54 31.48 30.53 31.48 0.9270158 30.7575 1.085717888 1.465 
-
0.554166667 
436 7 LEP 30.56 30.72 30.49 30.34 0.157771 30.5275 
    
#DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 
436 12 LPL 29.69 29.73 29.82 29.75 0.054391 29.7475 28.96 28.97 30.46 30.38 0.8406892 29.6925 0.842446833 -0.055 0 
436 1 LPL 29.96 29.36 29.27 28.58 0.565177 29.2925 26.82 26.93 27.76 27.38 0.4325409 27.2225 0.711699843 -2.07 -2.015 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
436 7 LPL 30.56 30.72 30.49 30.34 0.157771 30.5275 25.68 25.57 25.51 25.48 0.0883176 25.56 0.18080837 -4.9675 -4.9125 
436 12 SCD 29.69 29.73 29.82 29.75 0.054391 29.7475 25.75 25.34 26.5 25.68 0.48897 25.8175 0.491985772 -3.93 0 
436 1 SCD 29.96 29.36 29.27 28.58 0.565177 29.2925 26.58 26.9 27.52 26.66 0.4256368 26.915 0.707525029 -2.3775 1.5525 
436 7 SCD 30.56 30.72 30.49 30.34 0.157771 30.5275 25.88 25.9 26.65 26.33 0.3703152 26.19 0.402523291 -4.3375 -0.4075 
525 12 ADIPOQ 28.63 28.46 28.34 28.51 0.120139 28.485 27.72 27.77 27 27.66 0.361144 27.5375 0.380602592 -0.9475 0 
525 1 ADIPOQ 
 
31.41 
  
#DIV/0! 31.41 
 
32.55 31.92 
 
0.4454773 32.235 #DIV/0! 0.825 1.7725 
525 7 ADIPOQ 29.73 30.44 29.56 29.76 0.388448 29.8725 32.37 31.55 31.62 30.54 0.7513987 31.52 0.845867405 1.6475 2.595 
525 12 AR2 28.63 28.46 28.34 28.51 0.120139 28.485 29.39 29.68 29.88 30.63 0.5296854 29.895 0.543139025 1.41 0 
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525 1 AR2 
 
31.41 
  
#DIV/0! 31.41 
    
#DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 
525 7 AR2 29.73 30.44 29.56 29.76 0.388448 29.8725 
    
#DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 
525 12 LEP 28.63 28.46 28.34 28.51 0.120139 28.485 
 
28.86 28.81 
 
0.0353553 28.835 0.125233116 0.35 0 
525 1 LEP 
 
31.41 
  
#DIV/0! 31.41 
    
#DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 
525 7 LEP 29.73 30.44 29.56 29.76 0.388448 29.8725 
    
#DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 
525 12 LPL 28.63 28.46 28.34 28.51 0.120139 28.485 28.74 28.9 29.42 28.48 0.3964425 28.885 0.414246304 0.4 0 
525 1 LPL 
 
31.41 
  
#DIV/0! 31.41 28.48 27.96 27.92 27.96 0.2673325 28.08 #DIV/0! -3.33 -3.73 
525 7 LPL 29.73 30.44 29.56 29.76 0.388448 29.8725 30.72 29.7 30.2 30.93 0.551566 30.3875 0.674623352 0.515 0.115 
525 12 SCD 28.63 28.46 28.34 28.51 0.120139 28.485 24.45 24.61 24.69 24.49 0.1101514 24.56 0.162992842 -3.925 0 
525 1 SCD 
 
31.41 
  
#DIV/0! 31.41 28.49 28.38 27.93 28.48 0.2647011 28.32 #DIV/0! -3.09 0.835 
525 7 SCD 29.73 30.44 29.56 29.76 0.388448 29.8725 
 
32.51 31.51 31.3 0.646555 31.77333 0.754271171 1.90083333 5.825833333 
540 12 ADIPOQ 25.26 24.8 24.83 24.62 0.271339 24.8775 22.45 21.68 21.55 21.42 0.4623491 21.775 0.536089234 -3.1025 0 
540 1 ADIPOQ 23.5 23.74 23.35 22.35 0.611474 23.235 20.31 18.98 19.63 18.99 0.6328441 19.4775 0.879995265 -3.7575 -0.655 
540 7 ADIPOQ 25.79 25.58 25.75 24.77 0.477101 25.4725 22.37 21.43 21.38 21.5 0.4692547 21.67 0.66919728 -3.8025 -0.7 
540 12 AR2 25.26 24.8 24.83 24.62 0.271339 24.8775 24.36 24.35 24.67 24.49 0.1493039 24.4675 0.30970416 -0.41 0 
540 1 AR2 23.5 23.74 23.35 22.35 0.611474 23.235 23.77 23.8 24.7 24.49 0.4756049 24.19 0.774661216 0.955 1.365 
540 7 AR2 25.79 25.58 25.75 24.77 0.477101 25.4725 24.83 25.45 24.75 25.62 0.4369115 25.1625 0.646928641 -0.31 0.1 
540 12 LEP 25.26 24.8 24.83 24.62 0.271339 24.8775 26 25.75 25.66 25.75 0.1462874 25.79 0.308261253 0.9125 0 
540 1 LEP 23.5 23.74 23.35 22.35 0.611474 23.235 26.47 26.51 25.46 25.27 0.6543381 25.9275 0.895577095 2.6925 1.78 
540 7 LEP 25.79 25.58 25.75 24.77 0.477101 25.4725 26.58 24.22 23.55 24.73 1.2998205 24.77 1.384614868 -0.7025 -1.615 
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Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
540 12 LPL 25.26 24.8 24.83 24.62 0.271339 24.8775 25.39 24.82 25.62 25.52 0.3576194 25.3375 0.448906078 0.46 0 
540 1 LPL 23.5 23.74 23.35 22.35 0.611474 23.235 23.61 23.9 24.36 24.44 0.3921203 24.0775 0.726400945 0.8425 0.3825 
540 7 LPL 25.79 25.58 25.75 24.77 0.477101 25.4725 24.75 24.74 24.68 24.85 0.0704746 24.755 0.482277583 -0.7175 -1.1775 
540 12 SCD 25.26 24.8 24.83 24.62 0.271339 24.8775 24.95 25.43 25.3 25.27 0.2038586 25.2375 0.339386702 0.36 0 
540 1 SCD 23.5 23.74 23.35 22.35 0.611474 23.235 26.39 25.94 26.88 26.36 0.3844802 26.3925 0.722305337 3.1575 2.7975 
540 7 SCD 25.79 25.58 25.75 24.77 0.477101 25.4725 20.3 20.54 20.85 20.51 0.2267157 20.55 0.52822817 -4.9225 -5.2825 
439 12 ADIPOQ 31.25 30.37 30.58 29.76 0.614546 30.49 31.39 30.54 30.83 29.74 0.6874348 30.625 0.92208098 0.135 0 
439 7 ADIPOQ 
  
32.49 
 
#DIV/0! 32.49 
   
33.43 #DIV/0! 33.43 #DIV/0! 0.94 0.805 
439 12 AR2 31.25 30.37 30.58 29.76 0.614546 30.49 
   
31.41 #DIV/0! 31.41 #DIV/0! 0.92 0 
439 7 AR2 
  
32.49 
 
#DIV/0! 32.49 
    
#DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 
439 12 LEP 31.25 30.37 30.58 29.76 0.614546 30.49 
   
27.21 #DIV/0! 27.21 #DIV/0! -3.28 0 
439 7 LEP 
  
32.49 
 
#DIV/0! 32.49 
    
#DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 
439 12 LPL 31.25 30.37 30.58 29.76 0.614546 30.49 29.49 29.45 29.5 29.43 0.0330404 29.4675 0.615433452 -1.0225 0 
439 7 LPL 
  
32.49 
 
#DIV/0! 32.49 28.46 28.37 28.53 27.99 0.2407454 28.3375 #DIV/0! -4.1525 -3.13 
439 12 SCD 31.25 30.37 30.58 29.76 0.614546 30.49 
 
28.36 28.53 27.77 0.3988734 28.22 0.732643615 -2.27 0 
439 7 SCD 
  
32.49 
 
#DIV/0! 32.49 29.42 30.32 29.85 29.63 0.3856164 29.805 #DIV/0! -2.685 -0.415 
 
Appendix 2. The Ct values of EIF3K, PPAR, AR1 and HSL 
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Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
440 12 
PPAR-
gamma 
               
24.47  
               
24.49  
               
23.95  
               
23.82  0.3476948 24.1825 
               
22.41  
               
21.95  
               
22.42  
               
21.96  0.2656439 22.185 0.4375595 -1.9975 0 
440 1 
PPAR-
gamma 
               
27.41  
               
27.40  
               
27.30  
               
26.57  0.4030715 27.17 
               
24.36  
               
24.53  
               
24.73  
               
24.51  0.1519594 24.5325 0.4307648 -2.6375 -0.64 
440 7 
PPAR-
gamma 
               
26.75  
               
26.71  
               
26.72  
               
26.47  0.129454 26.6625 
               
24.68  
               
24.68  
               
24.40  
               
24.38  0.1676305 24.535 0.2117979 -2.1275 -0.13 
440 12 AR1 
               
24.47  
               
24.49  
               
23.95  
               
23.82  0.3476948 24.1825 
               
28.74  
               
28.64  
               
28.82  
               
28.93  0.1228481 28.7825 0.3687592 4.6 0 
440 1 AR1 
               
27.41  
               
27.40  
               
27.30  
               
26.57  0.4030715 27.17 
               
31.84  
               
32.39  
               
32.38  
               
32.89  0.4288356 32.375 0.5885292 5.205 0.605 
440 7 AR1 
               
26.75  
               
26.71  
               
26.72  
               
26.47  0.129454 26.6625 
               
31.36  
               
31.61  
               
31.76  
               
31.64  0.168003 31.5925 0.2120927 4.93 0.33 
440 12 HSL 
               
24.47  
               
24.49  
               
23.95  
               
23.82  0.3476948 24.1825 
               
26.94  
               
26.84  
               
26.78  
               
26.93  0.0763217 26.8725 0.3559728 2.69 0 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
440 1 HSL 
               
27.41  
               
27.40  
               
27.30  
               
26.57  0.4030715 27.17 
               
26.44  
               
26.79  
               
26.74  
               
26.37  0.2107922 26.585 0.4548626 -0.585 -3.275 
440 7 HSL 
               
26.75  
               
26.71  
               
26.72  
               
26.47  0.129454 26.6625 
               
30.57  
               
30.88  
               
30.80  
               
31.51  0.4020779 30.94 0.4224038 4.2775 1.5875 
560 12 
PPAR-
gamma 
               
29.76  
               
29.96  
               
30.42  
               
29.71  0.3235609 29.9625 
               
29.31  
               
30.46  
               
29.76  
               
29.82  0.4733128 29.8375 0.5733382 -0.125 0 
560 1 
PPAR-
gamma 
               
27.85  
               
26.79  
               
27.55  
               
26.73  0.5568962 27.23 
               
24.81  
               
24.62  
               
25.34  
               
25.58  0.4479118 25.0875 0.7146736 -2.1425 -2.0175 
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560 7 
PPAR-
gamma 
               
27.63  
               
26.80  
               
26.72  
               
26.43  0.5151375 26.895 
               
23.83  
               
23.98  
               
24.53  
               
23.98  0.3082207 24.08 0.6003055 -2.815 -2.69 
560 12 AR1 
               
29.76  
               
29.96  
               
30.42  
               
29.71  0.3235609 29.9625 
               
35.34  
               
35.70  
               
35.90  
               
35.47  0.2479751 35.6025 0.4076559 5.64 0 
560 1 AR1 
               
27.85  
               
26.79  
               
27.55  
               
26.73  0.5568962 27.23 
               
33.63  
               
33.76  
               
32.93  
               
33.56  0.369414 33.47 0.6682814 6.24 0.6 
560 7 AR1 
               
27.63  
               
26.80  
               
26.72  
               
26.43  0.5151375 26.895 
               
32.00  
               
32.83  
               
32.87  
               
33.52  0.6229232 32.805 0.8083316 5.91 0.27 
560 12 HSL 
               
29.76  
               
29.96  
               
30.42  
               
29.71  0.3235609 29.9625 
 
               
32.75  
  
#DIV/0! 32.75 #DIV/0! 2.7875 0 
560 1 HSL 
               
27.85  
               
26.79  
               
27.55  
               
26.73  0.5568962 27.23 
              
32.52  
               
33.69  
  
0.8273149 33.105 0.997288 5.875 3.0875 
560 7 HSL 
               
27.63  
               
26.80  
               
26.72  
               
26.43  0.5151375 26.895 
               
31.87  
               
31.92  
              
32.86  
              
31.70  0.5235376 32.0875 0.7344783 5.1925 2.405 
544 12 
PPAR-
gamma 
               
31.62  
               
31.69  
               
31.50  
               
32.53  0.4699291 31.835 
               
30.87  
               
30.86  
               
30.69  
               
30.56  0.1484363 30.745 0.492815 -1.09 0 
544 1 
PPAR-
gamma 
               
28.45  
               
27.82  
               
27.90  
               
27.52  0.3878466 27.9225 
               
25.53  
               
25.58  
               
25.50  
               
25.77  0.1212436 25.595 0.4063558 -2.3275 -1.2375 
544 7 
PPAR-
gamma 
               
28.96  
               
29.26  
               
29.28  
               
28.76  0.2505328 29.065 
               
28.99  
               
28.57  
               
28.51  
               
28.56  0.2232151 28.6575 0.3355468 -0.4075 0.6825 
544 12 AR1 
               
31.62  
               
31.69  
               
31.50  
               
32.53  0.4699291 31.835 
               
36.93  
               
35.92  
               
38.82  
               
39.63  1.7007939 37.825 1.7645207 5.99 0 
544 1 AR1 
               
28.45  
               
27.82  
               
27.90  
               
27.52  0.3878466 27.9225 
               
31.35  
               
31.73  
               
31.82  
               
31.60  0.2043689 31.625 0.4383967 3.7025 -2.2875 
544 7 AR1 
               
28.96  
               
29.26  
               
29.28  
               
28.76  0.2505328 29.065 
               
35.99  
               
34.96  
               
36.97  
               
36.72  0.9015912 36.16 0.9357528 7.095 1.105 
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544 12 HSL 
               
31.62  
               
31.69  
               
31.50  
               
32.53  0.4699291 31.835 
               
33.98  
 
               
32.32  
               
32.42  0.9308777 32.906667 1.0427688 1.0716667 0 
544 1 HSL 
               
28.45  
               
27.82  
               
27.90  
               
27.52  0.3878466 27.9225 
               
31.77  
              
30.93  
               
31.59  
               
31.64  0.3760652 31.4825 0.5402314 3.56 2.4883333 
544 7 HSL 
               
28.96  
               
29.26  
               
29.28  
               
28.76  0.2505328 29.065 
               
30.89  
               
31.71  
               
31.45  
               
30.75  0.4550458 31.2 0.5194548 2.135 1.0633333 
449 12 
PPAR-
gamma 
               
29.51  
               
29.62  
               
29.74  
               
29.36  0.1617354 29.5575 
               
27.77  
               
27.91  
               
28.35  
               
27.51  0.3515205 27.885 0.3869431 -1.6725 0 
449 1 
PPAR-
gamma 
               
27.82  
               
27.30  
               
27.86  
               
26.98  0.425049 27.49 
               
24.96  
               
24.92  
               
24.96  
               
25.44  0.2473863 25.07 0.4917994 -2.42 -0.7475 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
449 7 
PPAR-
gamma 
               
24.51  
               
24.85  
               
24.84  
               
24.35  0.2483781 24.6375 
               
22.63  
               
22.67  
               
22.69  
               
22.56  0.057373 22.6375 0.2549183 -2 -0.3275 
449 12 AR1 
               
29.51  
               
29.62  
               
29.74  
               
29.36  0.1617354 29.5575 
               
37.49  
               
36.75  
               
36.55  
               
35.41  0.8608523 36.55 0.8759138 6.9925 0 
449 1 AR1 
               
27.82  
               
27.30  
               
27.86  
               
26.98  0.425049 27.49 
               
32.77  
               
32.78  
               
32.73  
               
32.94  0.0925563 32.805 0.4350096 5.315 -1.6775 
449 7 AR1 
               
24.51  
               
24.85  
               
24.84  
               
24.35  0.2483781 24.6375 
               
28.42  
               
28.53  
               
28.43  
               
28.60  0.0858293 28.495 0.2627895 3.8575 -3.135 
449 12 HSL 
               
29.51  
               
29.62  
               
29.74  
               
29.36  0.1617354 29.5575 
               
31.77  
               
31.61  
               
32.32  
               
32.40  0.3936581 32.025 0.4255878 2.4675 0 
449 1 HSL 
               
27.82  
               
27.30  
               
27.86  
               
26.98  0.425049 27.49 
               
29.49  
               
29.50  
               
29.80  
               
30.33  0.3938697 29.78 0.5794825 2.29 -0.1775 
449 7 HSL 
               
24.51  
               
24.85  
               
24.84  
               
24.35  0.2483781 24.6375 
               
25.41  
               
24.94  
               
25.51  
               
24.96  0.2973774 25.205 0.3874597 0.5675 -1.9 
48 
 
 
510 12 PPAR-gamma 
 
               
34.87  
 
#DIV/0! 34.87 
  
               
37.87  
               
38.79  0.6505382 38.33 #DIV/0! 3.46 0 
510 1 
PPAR-
gamma 
               
28.68  
              
28.75  
               
28.54  
              
28.63  0.0883176 28.65 
              
28.52  
              
28.98  
               
29.62  
               
29.49  0.5040751 29.1525 0.5117535 0.5025 -2.9575 
510 7 
PPAR-
gamma 
               
26.36  
               
25.89  
               
25.89  
               
25.74  0.2694439 25.97 
               
23.78  
               
24.32  
               
23.44  
               
23.85  0.3623419 23.8475 0.4515436 -2.1225 -5.5825 
510 12 AR1 
  
               
34.87  
 
#DIV/0! 34.87 
    
#DIV/0! #DIV/0! #DIV/0! #DIV/0! #DIV/0! 
510 1 AR1 
              
28.68  
              
28.75  
               
28.54  
              
28.63  0.0883176 28.65 
              
34.70  
              
35.60  
              
36.31  
              
35.91  0.6847384 35.63 0.6904105 6.98 #DIV/0! 
510 7 AR1 
               
26.36  
               
25.89  
               
25.89  
               
25.74  0.2694439 25.97 
               
29.72  
               
29.57  
               
28.84  
               
30.57  0.7097652 29.675 0.7591882 3.705 #DIV/0! 
510 12 HSL 
  
               
34.87  
 
#DIV/0! 34.87 
               
39.00  
   
#DIV/0! 39 #DIV/0! 4.13 0 
510 1 HSL 
              
28.68  
              
28.75  
               
28.54  
              
28.63  0.0883176 28.65 
 
              
33.38  
              
32.65  
              
34.35  0.8528189 33.46 0.8573797 4.81 0.68 
510 7 HSL 
               
26.36  
               
25.89  
               
25.89  
               
25.74  0.2694439 25.97 
              
29.32  
               
29.84  
               
29.92  
               
29.50  0.2830194 29.645 0.3907685 3.675 -0.455 
403 12 
PPAR-
gamma 25.33 24.95 24.81 24.64 0.2937544 24.9325 24.82 23.51 23.64 23.99 0.5892934 23.99 0.6584515 -0.9425 0 
403 1 
PPAR-
gamma 23.64 24.47 24.52 23.95 0.423989 24.145 23.98 24.28 24.44 23.59 0.3739318 24.0725 0.5653244 -0.0725 0.87 
403 7 
PPAR-
gamma 25.36 25.65 25.36 24.81 0.3510461 25.295 23.45 23.38 23.91 22.99 0.3772157 23.4325 0.5152912 -1.8625 -0.92 
403 12 AR1 25.33 24.95 24.81 24.64 0.2937544 24.9325 30.43 30.49 30.6 30.61 0.0873212 30.5325 0.3064583 5.6 0 
49 
 
 
403 1 AR1 23.64 24.47 24.52 23.95 0.423989 24.145 29.58 29.93 29.89 29.74 0.1592692 29.785 0.4529165 5.64 0.04 
403 7 AR1 25.36 25.65 25.36 24.81 0.3510461 25.295 29.75 29.47 29.72 30.27 0.3359936 29.8025 0.4859269 4.5075 -1.0925 
403 12 HSL 25.33 24.95 24.81 24.64 0.2937544 24.9325 30.84 30.5 30.51 32.58 0.9942962 31.1075 1.0367819 6.175 0 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
403 1 HSL 23.64 24.47 24.52 23.95 0.423989 24.145 28.58 27.95 28.94 28.45 0.409634 28.48 0.5895478 4.335 -1.84 
403 7 HSL 25.36 25.65 25.36 24.81 0.3510461 25.295 28.73 29 28.73 28.57 0.1783956 28.7575 0.3937745 3.4625 -2.7125 
459 12 
PPAR-
gamma 25.4 26.33 25.96 25.99 0.3851407 25.92 23.89 23.88 24.58 23.76 0.3730393 24.0275 0.5361825 -1.8925 0 
459 1 
PPAR-
gamma 23.81 24.48 23.99 23.76 0.3285321 24.01 22.34 
 
21.91 21.92 0.2454248 22.056667 0.4100813 
-
1.9533333 -0.0608333 
459 7 
PPAR-
gamma 24.85 25.43 25.55 25.69 0.3689625 25.38 25.39 25.44 25.41 25.41 0.0206155 25.4125 0.369538 0.0325 1.925 
459 12 AR1 25.4 26.33 25.96 25.99 0.3851407 25.92 30.7 30.27 30.53 30.75 0.2165448 30.5625 0.4418427 4.6425 0 
459 1 AR1 23.81 24.48 23.99 23.76 0.3285321 24.01 27.51 27.34 27.38 27.43 0.0732575 27.415 0.3366007 3.405 -1.2375 
459 7 AR1 24.85 25.43 25.55 25.69 0.3689625 25.38 29.87 29.86 30.83 30.48 0.4779819 30.26 0.6038212 4.88 0.2375 
459 12 HSL 25.4 26.33 25.96 25.99 0.3851407 25.92 28.92 28.44 29.65 28.43 0.5741661 28.86 0.6913754 2.94 0 
459 1 HSL 23.81 24.48 23.99 23.76 0.3285321 24.01 24.52 24.52 24.66 24.81 0.1384136 24.6275 0.3564992 0.6175 -2.3225 
459 7 HSL 24.85 25.43 25.55 25.69 0.3689625 25.38 29.33 28.79 28.77 29.4 0.3390551 29.0725 0.5010905 3.6925 0.7525 
447 12 
PPAR-
gamma 23.64 23.64 23.52 23.59 0.0567891 23.5975 21.72 21.71 21.83 21.6 0.0939858 21.715 0.1098104 -1.8825 0 
447 1 
PPAR-
23.81 24.38 24.28 24.28 0.2560436 24.1875 22.99 22.94 23.33 22.72 0.2522565 22.995 0.3594324 -1.1925 0.69 
50 
 
 
gamma 
447 7 
PPAR-
gamma 24.53 25.33 24.93 24.88 0.3275541 24.9175 22.43 22.64 22.56 22.59 0.0896289 22.555 0.3395953 -2.3625 -0.48 
447 12 AR1 23.64 23.64 23.52 23.59 0.0567891 23.5975 27.58 27.59 27.93 27.78 0.1675311 27.72 0.1768945 4.1225 0 
447 1 AR1 23.81 24.38 24.28 24.28 0.2560436 24.1875 28.36 28.8 28.76 28.73 0.203695 28.6625 0.327185 4.475 0.3525 
447 7 AR1 24.53 25.33 24.93 24.88 0.3275541 24.9175 28.39 28.59 29.32 28.66 0.4032369 28.74 0.519511 3.8225 -0.3 
447 12 HSL 23.64 23.64 23.52 23.59 0.0567891 23.5975 26.67 26.81 27.39 26.98 0.3119161 26.9625 0.3170436 3.365 0 
447 1 HSL 23.81 24.38 24.28 24.28 0.2560436 24.1875 27.92 27.71 28.35 27.84 0.2771883 27.955 0.3773482 3.7675 0.4025 
447 7 HSL 24.53 25.33 24.93 24.88 0.3275541 24.9175 26.74 26.74 27.59 27.43 0.4493328 27.125 0.5560501 2.2075 -1.1575 
455 12 
PPAR-
gamma 23.84 24.36 23.96 23.51 0.3510342 23.9175 20.96 20.95 21.33 20.91 0.1961929 21.0375 0.4021401 -2.88 0 
455 1 
PPAR-
gamma 23.4 23.48 23.57 23.6 0.0906918 23.5125 22.46 21.98 22.51 21.94 0.304234 22.2225 0.3174639 -1.29 1.59 
455 7 
PPAR-
gamma 23.31 23.32 23.29 22.7 0.3035896 23.155 21.77 21.72 21.94 21.65 0.1235584 21.77 0.3277702 -1.385 1.495 
455 12 AR1 23.84 24.36 23.96 23.51 0.3510342 23.9175 26.74 26.75 26.38 26.68 0.1744276 26.6375 0.3919821 2.72 0 
455 1 AR1 23.4 23.48 23.57 23.6 0.0906918 23.5125 27.29 26.83 26.84 26.88 0.2210581 26.96 0.2389386 3.4475 0.7275 
455 7 AR1 23.31 23.32 23.29 22.7 0.3035896 23.155 26.66 26.73 26.95 26.78 0.1235584 26.78 0.3277702 3.625 0.905 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
455 12 HSL 23.84 24.36 23.96 23.51 0.3510342 23.9175 21.72 21.8 22.45 21.82 0.3377746 21.9475 0.4871516 -1.97 0 
455 1 HSL 23.4 23.48 23.57 23.6 0.0906918 23.5125 22.7 23.36 23.42 22.83 0.3655475 23.0775 0.3766298 -0.435 1.535 
51 
 
 
455 7 HSL 23.31 23.32 23.29 22.7 0.3035896 23.155 22.88 22.93 22.8 22.89 0.0544671 22.875 0.3084369 -0.28 1.69 
460 12 
PPAR-
gamma 24.2 24.67 24.32 24.43 0.2000833 24.405 23.87 23.72 23.69 23.88 0.0989949 23.79 0.2232338 -0.615 0 
460 1 
PPAR-
gamma 23.67 23.9 23.7 23.65 0.115181 23.73 23.33 23.37 23.44 23.49 0.0713559 23.4075 0.1354929 -0.3225 0.2925 
460 7 
PPAR-
gamma 22.54 22.63 22.7 22.92 0.1621471 22.6975 21.74 21.87 21.55 21.63 0.1388944 21.6975 0.2135025 -1 -0.385 
460 12 AR1 24.2 24.67 24.32 24.43 0.2000833 24.405 28.94 28.74 28.92 28.75 0.1071992 28.8375 0.2269912 4.4325 0 
460 1 AR1 23.67 23.9 23.7 23.65 0.115181 23.73 27.97 28.34 28.47 28.31 0.2132878 28.2725 0.2424012 4.5425 0.11 
460 7 AR1 22.54 22.63 22.7 22.92 0.1621471 22.6975 26.52 26.53 26.63 26.57 0.0499166 26.5625 0.1696565 3.865 -0.5675 
460 12 HSL 24.2 24.67 24.32 24.43 0.2000833 24.405 26.52 26.69 26.71 26.52 0.1042433 26.61 0.2256103 2.205 0 
460 1 HSL 23.67 23.9 23.7 23.65 0.115181 23.73 25.39 25.73 25.69 25.59 0.1518771 25.6 0.190613 1.87 -0.335 
460 7 HSL 22.54 22.63 22.7 22.92 0.1621471 22.6975 23.36 22.82 23.44 23.36 0.2858321 23.245 0.3286209 0.5475 -1.6575 
436 12 
PPAR-
gamma 23.42 23.34 23.34 22.87 0.2511805 23.2425 21.39 20.71 20.72 20.83 0.3229422 20.9125 0.4091251 -2.33 0 
436 1 
PPAR-
gamma 24.38 23.93 23.88 24.32 0.2588919 24.1275 21.81 22.39 21.65 21.6 0.3628935 21.8625 0.4457765 -2.265 0.065 
436 7 
PPAR-
gamma 22.62 22.6 22.6 22.7 0.0476095 22.63 24.32 23.83 23.73 23.56 0.3262923 23.86 0.3297474 1.23 3.56 
436 12 AR1 23.42 23.34 23.34 22.87 0.2511805 23.2425 26.28 26.54 26.54 26.84 0.2289105 26.55 0.3398406 3.3075 0 
436 1 AR1 24.38 23.93 23.88 24.32 0.2588919 24.1275 26.66 26.97 26.73 26.86 0.1377195 26.805 0.2932434 2.6775 -0.63 
436 7 AR1 22.62 22.6 22.6 22.7 0.0476095 22.63 26.8 26.7 26.74 26.95 0.1096586 26.7975 0.1195478 4.1675 0.86 
52 
 
 
436 12 HSL 23.42 23.34 23.34 22.87 0.2511805 23.2425 22.43 22.54 22.71 22.52 0.1169045 22.55 0.2770529 -0.6925 0 
436 1 HSL 24.38 23.93 23.88 24.32 0.2588919 24.1275 20.78 20.93 20.89 20.71 0.1007886 20.8275 0.2778189 -3.3 -2.6075 
436 7 HSL 22.62 22.6 22.6 22.7 0.0476095 22.63 26.43 26.31 26.39 25.85 0.2680174 26.245 0.2722132 3.615 4.3075 
525 12 
PPAR-
gamma 25.96 26.28 26.41 25.91 0.2434475 26.14 24.35 24.45 24.49 24.5 0.0684957 24.4475 0.2528998 -1.6925 0 
525 1 
PPAR-
gamma 30.67 30.45 29.83 30.46 0.3628016 30.3525 28.58 28.54 28.3 28 0.2670206 28.355 0.450472 -1.9975 -0.305 
525 7 
PPAR-
gamma 28.8 28.53 28.4 28.51 0.1699019 28.56 27.27 26.94 27.29 26.83 0.2325762 27.0825 0.2880249 -1.4775 0.215 
525 12 AR1 25.96 26.28 26.41 25.91 0.2434475 26.14 29.65 29.97 30.27 29.98 0.253295 29.9675 0.3513189 3.8275 0 
525 1 AR1 30.67 30.45 29.83 30.46 0.3628016 30.3525 31.84 32.38 33.56 32.31 0.7320462 32.5225 0.8170169 2.17 -1.6575 
Animal Time Gene EIF3K EIF3K EIF3K EIF3K SD Caverage Sample1 Sample2 Sample3 Sample4 SD Saverage SD_deltaCt deltaCt 
deltadeltaCt 
(Ct-colCt) 
525 7 AR1 28.8 28.53 28.4 28.51 0.1699019 28.56 32.42 33.31 32.56 32.9 0.3966842 32.7975 0.4315379 4.2375 0.41 
525 12 HSL 25.96 26.28 26.41 25.91 0.2434475 26.14 24.84 24.77 24.72 24.64 0.084212 24.7425 0.2576011 -1.3975 0 
525 1 HSL 30.67 30.45 29.83 30.46 0.3628016 30.3525 31.59 30.32 30.82 31.53 0.6074263 31.065 0.707525 0.7125 2.11 
525 7 HSL 28.8 28.53 28.4 28.51 0.1699019 28.56 29.71 30.31 28.82 29.74 0.6153861 29.645 0.6384095 1.085 2.4825 
540 12 
PPAR-
gamma 24.77 24.93 24.9 24.94 0.0785281 24.885 22.47 21.92 22.4 22.43 0.2582634 22.305 0.2699383 -2.58 0 
540 1 
PPAR-
gamma 26.61 26.57 26.42 26.49 0.0846069 26.5225 23.97 23.8 23.89 23.94 0.0743864 23.9 0.1126573 -2.6225 -0.0425 
540 7 
PPAR-
gamma 24.9 25.42 25.44 25.39 0.2591492 25.2875 23.56 23.37 23.24 23.28 0.1424488 23.3625 0.2957195 -1.925 0.655 
53 
 
 
540 12 AR1 24.77 24.93 24.9 24.94 0.0785281 24.885 28.89 28.95 29.41 29.3 0.2563039 29.1375 0.268064 4.2525 0 
540 1 AR1 26.61 26.57 26.42 26.49 0.0846069 26.5225 30.48 30.6 30.68 30.87 0.1637834 30.6575 0.1843457 4.135 -0.1175 
540 7 AR1 24.9 25.42 25.44 25.39 0.2591492 25.2875 29.32 29.47 29.63 29.3 0.1534058 29.43 0.3011506 4.1425 -0.11 
540 12 HSL 24.77 24.93 24.9 24.94 0.0785281 24.885 26.32 25.96 26.75 26.53 0.3361547 26.39 0.3452053 1.505 0 
540 1 HSL 26.61 26.57 26.42 26.49 0.0846069 26.5225 26.58 26.43 26.73 26.66 0.128841 26.6 0.1541374 0.0775 -1.4275 
540 7 HSL 24.9 25.42 25.44 25.39 0.2591492 25.2875 26.37 26.36 26.36 26.51 0.0734847 26.4 0.2693665 1.1125 -0.3925 
439 12 
PPAR-
gamma 27.34 27.69 27.33 27.27 0.1908533 27.4075 25.32 25.33 25.35 25.43 0.0499166 25.3575 0.1972731 -2.05 0 
439 7 
PPAR-
gamma 33.56 34.64 32.33 35.2 1.2667379 33.9325 30.62 30.83 31.38 31.41 0.3964005 31.06 1.3273124 -2.8725 -0.8225 
439 12 AR1 27.34 27.69 27.33 27.27 0.1908533 27.4075 30.92 32.42 31.35 31.84 0.6456715 31.6325 0.673288 4.225 0 
439 7 AR1 33.56 34.64 32.33 35.2 1.2667379 33.9325 31.71 31.44 32.46 31.56 0.458503 31.7925 1.3471637 -2.14 -6.365 
439 12 HSL 27.34 27.69 27.33 27.27 0.1908533 27.4075 28.53 29.33 29.27 28.55 0.4395452 28.92 0.479192 1.5125 0 
439 7 HSL 33.56 34.64 32.33 35.2 1.2667379 33.9325 34.28 
   
#DIV/0! 34.28 #DIV/0! 0.3475 -1.165 
  
 
